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ABSTRACT 
Human Papillomavirus (HPV) is the most prevalent sexually transmitted infection in the United 
States. Many individuals, however, are misinformed about key aspects of the STI, negatively view the 
disease and those infected with it, and do not use preventive methods to protect themselves and others 
from transmission. For this study, I used in-person, semi-structured interviews to examine HPV 
knowledge among those with HPV and how this knowledge impacted individuals’ emotional state upon 
diagnosis. I also analyzed feelings of stigma among individuals with HPV and how these feelings and HPV 
knowledge impacted individuals’ motivations to disclose their status to others. I also examined status 
disclosure and sexual behavior among those with HPV and how HPV transmission knowledge impacted 
motivations and intentions to participate in prevention behaviors. I found that post-diagnosis many 
individuals were ill-informed about HPV transmission, dormancy, prevalence, clearance, impact on men, 
and association with cervical cancer. I also found that post-diagnosis many individuals were anxious and 
upset about their positive status and felt judged by some individuals in their lives. Confronting and 
 vi 
internalizing this stigma impacted how and why they disclosed and withheld their positive HPV status. I 
also found that few individuals with HPV disclosed their status to all at-risk sex partners or used barrier 
methods consistently during sex. These findings suggest that practitioners’ messages and sexual 
education about HPV are inadequate. More work is needed to facilitate effective and empathetic 
patient-provider communication and HPV education that includes status disclosure and use of all barrier 
methods. These findings also suggest that the culture around HPV needs to change so that individuals 
with a positive status no longer undergo undue stress and can openly educate others about the STI.  
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1 INTRODUCTION  
1.1 OVERVIEW OF ISSUE 
Human Papillomavirus (HPV), a sexually transmitted infection, is a highly prevalent disease 
(Brewer and Fazekas 2007; CDC 2017a; McCaffery et al. 2004; McCaffery et al. 2006; Nan 2012; Waller 
et al. 2007b). It is, in fact, so common that nearly all sexually active individuals will contract at least one 
type of HPV during their lifetime (Braun and Phoun 2010; CDC 2017a). Approximately 79 million 
Americans are infected with HPV, with 14 million becoming newly infected annually (CDC 2017a). There 
are over 100 types of HPV and, although most HPV infections are asymptomatic and transient (usually 
clearing within two year), other HPV infection types can cause genital warts and/or lead to cervical, 
vaginal, vulvar, penile, anal, and throat cancer in men and women (CDC 2016; CDC 2017a).  
HPV is the primary cause of cervical cancer in the U.S. (Nan 2012). Out of the 100+ infections of 
HPV, HPV16 and HPV18 are associated with the majority of cervical cancer cases (CDC 2013; Polzer and 
Knabe 2012). In the United States, 3,700 women die from this type of cancer each year (2.3/100,000 
death rate for cervical cancer) (Connell and Hunt 2010; Grantham et al. 2011; USCSWG 2014). In other 
words, a woman not vaccinated against HPV has a 1 percent lifetime risk of developing cervical cancer 
(Chapman 2010). The cervical cancer incidence and death rates are higher among Latina and Black 
women (10.2/100,000 and 9.4/100,000 respectively; 2.8/100,000 and 4.1/100,000 respectively) 
compared to White women (7.8/100,000 and 2.1/100,000) (CDC 2014) in the United States. Anal, head, 
neck, penile, vaginal, and vulvar cancers, although rare, are also associated with high-risk HPV (CDC 
2017c; ASHA 2018). Over 80% of anal cancers, 70% of head and neck cancers, 60% of penile cancers, and 
70% of vaginal and vulvar cancers in the United States are associated with high-risk HPV (CDC 2017c; 
ASHA 2018).  
Individuals tend to be more aware of HPV’s link to cervical cancer than to other cancers; 
however, 38% of Americans are unsure or do not know that HPV causes cervical cancer (Blake et al 
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2015). Even individuals who are knowledgeable about HPV’s link to cervical cancer tend to be unaware 
that it is transient in nature and can resolve on its own within a few years (Gerend and Magloire 2008; 
Sandfort and Pleasant 2009; Ratanasiripong et al. 2013; Blake et al. 2015). Many Americans are unaware 
of the highly prevalent and easily transmittable nature of HPV and do not perceive themselves as at risk 
(Blake et al. 2015; Gerend and Magloire 2008; Sandfort and Pleasant 2009; Ratanasiripog et al. 2013).  
Nearly 70% of Americans are aware of the HPV vaccine (Blacke et al. 2015). The HPV vaccine 
protects against persistent infection of HPV subtypes associated with cancers and anogenital warts 
(Rothman 2009; Brelsford 2011). According to clinical trials, the vaccine prevents 90-100% of new high 
risk HPV infections among women (aged 15-26) not infected with HPV at time of vaccination (Herrero et 
al. 2015). In June of 2006, the HPV vaccine was approved and recommended for girls aged 11-26 
(allowing 9 and 10-year-old girls to be eligible for vaccine) (Braun and Phoun 2010; CDC 2011; Connell 
and Hunt 2010; Shefer et al. 2008; Wailoo et al. 2010). Vaccinations for boys and men aged 9-26 are 
now recommended due to the role they play in transmitting HPV, as well as their increased risk for 
cancer (anal, penile, neck), genital warts, and recurrent respiratory papillomatosis (tumors in the air 
passages) when infected with HPV, specifically types 6, 11, and 16 (Anic et al. 2011; Dunne et al. 2006; 
Elbasha and Dasbach 2010). 
HPV vaccination intention is lower among older adolescents and college age women. The most 
commonly cited barriers to vaccine intent among college age women were: vaccine safety concerns, side 
effects, insurance issues, cost, and low perceived risk (Patel et al. 2012). Among older adolescents and 
young adults, those more likely to receive the HPV vaccine are white, insured, 18 to 20 year old women 
(Laz et al. 2013). The most commonly cited barriers to vaccine intent and uptake among 18-26 year old 
women were: vaccine safety concerns, side effects, insurance issues, cost, low perceived risk, and belief 
they were too old to receive the vaccine (Laz et al. 2013; Patel et al. 2012). According to the CDC, the 
vaccine is not recommended for women over the age of 26 because it offered limited protection against 
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HPV-related diseases in clinical trials due to the fact that most women had already been exposed to one 
or more HPV strains in their late teens or early twenties (CDC 2017d). However, research suggests that 
the vaccine may be beneficial to older women, even those who are HPV positive. In fact, previously 
infected individuals may benefit from vaccination by increasing antibodies and thus helping individuals 
clear HPV more quickly and prevent re-infection (Muderspach et al. 2000; Scherer et al. 2016). 
 
1.2 THEORETICAL BACKGROUND 
In my dissertation, I sought to reveal the stories of individuals with HPV, as they discuss their 
experiences, understandings, and interpretations of living with HPV. Specifically, I aimed to analyze the 
connections between HPV knowledge and health literacy after diagnosis, patient-provider relationships, 
perceived stigma, disclosure, and sexual behavior. In order to highlight these issues, I relied on the 
following theoretical frameworks: stigma, health literacy, patient-provider communication model, and 
the information, motivation, behavior model. 
1.2.1 Health Literacy 
Patients are encouraged to be active and informed health care consumers (Parker 2010, Street 
& Epstein 2008). To do so, they must have a high level of health literacy, defined as the “degree to which 
an individual has the capacity to obtain, communicate, process, and understand basic health 
information and services to make appropriate health decisions” (CDC 2016b: n.p.). Patients with high 
health literacy are capable of finding health information and services, communicating their needs, 
processing meanings of information, understanding choices and consequences, and deciding what 
services meet their need (CDC 2016b). To aid in the development of health literacy, providers should 
help patients find information and services, communicate about health and healthcare, process patient 
questions and preferences, understand how to provide useful information, and decide what information 
and services are best for specific situations (CDC 2016b). Level of HPV health literacy is often related to 
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age, gender, socioeconomic status and race (Kutner 2006). According to research, young, white, 
educated women are more knowledgeable about HPV compared to men, the elderly, individuals with no 
college education, and women from racial and ethnic minority groups (Blake et al. 2015; Gerend and 
Magloire 2008; Gerend and Shepherd 2011; Holcomb et al. 2004; Jain et al. 2009; Reimer et al. 2014; 
Pruitt et al. 2005; Sandfort and Pleasant 2009; Tiro et al. 2007).   
 
1.2.2 Patient-Provider Communication 
Individuals who feel they have a strong relationship with their doctor, compared to those who 
do not, can have improved health because they are more satisfied, more likely to heed doctors’ 
recommendations, and are more committed to treatment plans (Fuertes et al 2007). Patients would 
prefer to have providers who are informative, emotionally supportive, and with whom they share 
mutual trust, respect, and engagement (Aelbrecht et al. 2014; Mazzi et al. 2015; Fuertes et al 2007; 
Fuertes et al. 2016). By openly communicating with patients, doctors can better understand patients’ 
health problems, answer patients’ questions, and heighten patients’ sense of control over their 
diagnoses (Iwamitsu et al 2003; Schofield et al. 2003; Street & Epstein 2008). 
Most women diagnosed with HPV tend to have many unanswered questions about their 
diagnosis because of the impersonal ways in which they were informed of their status (Harvey-Knowles 
and Kosenko 2012). Research indicates that most women do not fully understand HPV upon initial 
diagnosis because they are shocked by their diagnosis and lack the mental clarity to ask their doctor for 
details about HPV (Bertram and Magnussen 2008; Kosenko et al. 2014). Women also report that they 
receive confusing information from their doctors at time of diagnosis (Daley et al. 2008). Specifically, 
recently diagnosed individuals are confused about the symptoms, impact on fertility, treatment options, 
recommended lifestyle changes, impact on male sexual partners, how HPV differs from other STIs, which 
type of HPV they have, and how low-risk HPV differs from high-risk HPV (Bertram and Magnussen 2008; 
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Daley et al. 2008; Perrin et al. 2006). This lack of knowledge often occurred when health care providers 
use excessive medical jargon, allocate insufficient time to explain the diagnosis, seem insensitive to their 
patients, and lack an established patient-provider relationship (Bertram and Magnussen 2008).  
1.2.3 Theories of Stigma  
A less desirable attribute than one stereotypically assigned to persons of the same category is 
known as a “stigma” (Goffman 1963:3). Stigmas can be caused by character flaws, which are personality 
traits that deviate from those socially accepted or by physical deformities (Goffman 1963). Stigmatized 
individuals are perceived as dangerous to societal norms (Goffman 1963). Society often views women 
who stray from the societal norms of female chastity and purity as deviant, morally corrupt, 
irresponsible, unclean, and promiscuous (East et al. 2012; Nack 2008). Therefore, they possess a 
character stigma and risk negative judgment from others (Nack 2008). According to symbolic 
interactionists, individuals incorporate others’ evaluations of them when self-evaluating (Nack 2008:65). 
Women with HPV often feel embarrassed about their diagnosis and refer to themselves as “unclean, 
“dirty”, “cheap”, “gross” (Daley et al. 2008; East et al. 2012, 17; Nack 2008).  
When an individual’s dissimilarity is not obvious upon first meeting, they have a hidden 
“discreditable stigma,” and they must determine what to display or who to tell (Goffman 1963:42). 
According to Goffman, most individuals will intentionally pass if given the opportunity (1963). Women 
with HPV often choose not to disclose their stigma to others because they fear rejection from their 
friends, family, and sexual partners (Nack 2008:91). Individuals with a discreditable stigma may choose, 
however, to disclose their discreditable attribute to others as a form of “stigma management” (Breitkopf 
2004; Goffman 1963:100). Often, a discreditable person will reveal their shameful attribute to a few key 
individuals and then rely on those individuals for support (Goffman 1963). Many women disclose in 
order to gain the support, sympathy, and acceptance from close friends and family members (Lee and 
Craft 2002; Nack 2008:98).  
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More recent research on stigma, among individuals with STIs, draws on the Berger et al.’s HIV 
Stigma Scale. According to Berger et al., perceived stigma occurs in the context of (1) one’s perception 
of society’s attitudes toward a person with HIV and (2) one’s personal knowledge of being HIV positive 
(Berger et al. 2001). This perceived stigma can lead to a mal-adjusted sense of self , attempts to control 
who knows about one’s status, and even avoidance of potentially stigmatizing social situations (Berger 
et al. 2001). The HIV Stigma Scale evaluates personalized stigma, which relates to experiences and fears 
of rejection; disclosure concerns, related to controlling who knows their positive status; negative self-
image, related to shame and feeling like a bad person; and concerns with public attitudes, which relates 
to fear that larger society will judge a person with a positive status (Barnack-Tavlaris et al. 2016; Berger 
et al. 2001). Using this framework, HPV researchers have found that individuals with HPV most 
commonly cite feeling negative self-image stigma, whereby they feel dirty and disgusted with 
themselves for having HPV (Barnack-Tavlaris et al. 2016). Personalized stigma was also commonly felt by 
individuals with HPV, who worried that others would not understand their situation and reject them 
(Barnack-Tavlaris et al. 2016). Fewer people were concerned about disclosure, but those who limited 
their disclosure were worried about sexual rejection (Barnack-Tavlaris et al. 2016). Researchers found 
that individuals with HPV were less affected by public attitude compared to all other types of stigma 
(Barnack-Tavlaris et al. 2016).  
Attribution theorists posit that public attitude stigma impacts individuals more if they may be 
blamed for their serious illness (Lebel and Devins 2008; Weiner, Perry and Magnusson 1988). If a person 
participates in voluntary, avoidable, risky behavior that leads to their illness, larger society may view 
them negatively (Lebel and Devins 2008; Weiner, Perry and Magnusson 1988). Conversely, if an 
individual’s illness is deemed to be unavoidable by larger society they are often accepted and even 
pitied (Lebel and Devins 2008; Weiner, Perry and Magnusson 1988). Researchers found, when 
comparing the stigma felt by individuals with HIV compared to those with cancer, those with HIV felt 
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greater stigma which was, in part, due to HIV patients being viewed as responsible for their diagnosis 
(Fife and Wright 2000). Research specific to cancer-related stigma indicates the level of stigma and 
blame is associated with type of cancer. They found that blame is more often attributed to women with 
cervical cancer than to individuals with cancers unrelated to lifestyle choices, such as leukemia, breast, 
or bowel cancer (Marlow et al. 2010, 1802). Due to the fact that the large majority of cervical cancer 
cases are linked to high-risk HPV and HPV is acquired through skin-to-skin, oral, vaginal, and anal sexual 
contact, public opinion of individuals with HPV may be negative, as it is for individuals with HIV. 
Research indicates that women, specifically, with HPV are often viewed as deviant and irresponsible 
(East et al. 2012; Nack 2008) and may, therefore, feel more stigma than individuals with cancer whose 
behavior may not have contributed to their diagnosis (Lebel and Devins 2008). 
1.2.4 Information, Motivation, Behavior Model 
According to the “information, motivation, behavior” (IMB) theoretical model, STI prevention 
techniques are used by individuals who are well informed, perceive themselves to be at risk, are 
motivated to change their risky behavior, and feel capable of using prevention strategies (Bahrami and 
Zarani 2015; St. Lawrence and Fortenberry 2007). In order to participate in STI prevention behavior, they 
need to be knowledgeable about STI transmission and prevention methods (Fisher and Fisher 1992; St. 
Lawrence and Fortenberry 2007). HPV prevention methods include status disclosure to partners and 
consistent use of barrier methods, such as condoms and dental dams. According to past research, much 
of the general population is unaware of their risk of acquiring and transmitting HPV (Blake et al. 2015; 
Gerend and Magloire 2008; Sandfort and Pleasant 2009; Ratanasiripog et al. 2013). Although most of 
the general public is aware that HPV is an STI, many do not know that it is linked to genital warts and can 
be transmitted through skin-to-skin contact (Gerend and Magloire 2008; Sandfort and Pleasant 2009). 
Many individuals are also unaware that STI disclosure is a component of safer sex practices (Luchetti 
2009).  
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Informed individuals must be motivated to act on their knowledge and change their risky 
behavior to preventive behaviors (Fisher and Fisher 1992; St. Lawrence and Fortenberry 2007). One’s 
perceived susceptibility to risk and adherence to social norms surrounding prevention techniques are 
key components to motivation (Fisher and Fisher 1992). Consistent condom use is associated with 
perceived risk to STIs (Bryan et al. 1997). However, many people often do not perceive themselves at 
risk for HPV (Gerend and Magloire 2008; Sandfort and Pleasant 2009; Ratanasiripong et al. 2013; Blake 
et al. 2015). Individuals must also have the skills to perform the recommended preventive behaviors (St. 
Lawrence and Fortenberry 2007). For prevention of HPV transmission, these skills include: obtaining a 
vaccine, correct condom use, sexual communication, condom negotiation, and a sense of self-efficacy 
(Fisher and Fisher 1992).  For women, condom use self-efficacy involves agency over sexual 
communication and negotiation with partners (Artistico et al. 2014; French and Holland 2011). Women 
who perceive themselves to have less decision-making power in their relationship are less likely to 
report consistent condom use (Pulerwitz et al. 2002). 
 
1.3 METHODS 
For this study, I employed purposive, facility-based sampling and snowball sampling. I utilized 
key locations to find study participants, such the health clinic at a large public university in the 
Southeastern United States and multiple privately-operated gynecological clinics around a large 
metropolitan area in the Southeastern United States. I also posted flyers around two major universities, 
high-traffic pedestrian areas, and throughout diverse neighborhoods. Additionally, I gained entry into 
online support groups for individuals with HPV1 to recruit group members for my study. I displayed and 
distributed flyers at the recruitment facilities. Multiple versions of the flyer were distributed with 
                                                 
1 http://www.dailystrength.org/c/HPV/support-group; http://hpvsupport.com/phpBB3/; 
http://www.mdjunction.com/hpv; http://hpv.supportgroups.com/; http://www.hpvhope.com/support.html;  
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various photos of young girls and women from different racial and ethnic groups on them in order to 
appeal to a diverse group of potential participants. Each flyer contained tear-off tabs so that interested 
parties could easily obtain my contact information. Additionally, each flyer included a Quick Response 
code that linked smartphone users to my online eligibility form. This eligibility form required users to 
enter their age and HPV status and then, if eligible and interested in participating, their contact 
information was automatically sent to me.  
 
1.3.1 Sample Demographics 
My participants included 23 women of various ages2. Six were in their 20s, eleven in their 30s, three 
in their 40s, two in their 50s, and one over 60 years old. Age at diagnosis varied with three receiving 
there HPV diagnosis at age 19, seven receiving it in their early 20s, six in their late 20s, three in their 
early 30s, one at age 45, and one at age 60. My sample was a highly educated group, with 10 of my 
participants having obtained a graduate degree, four in graduate school at the time of interview, six 
obtaining a terminal Bachelor’s degree, one currently in undergraduate school at the time of interview, 
one having had some college education, and one having a GED as highest level of education. The 
majority of my participants (73.9%) were white, 21.7% were black, and 4.35% were multiracial. Ten of 
my participants were single at the time of interview, 8 were in a committed relationship, and 5 were 
legally married. In terms of gender identity, 22 of my participants identified as women and one 
identified as gender queer. In terms of sexual orientation, 18 classified themselves as heterosexual, one 
as lesbian, and four as bisexual.  
 
                                                 
2 My sample originally included 25 individuals, but after the interview, I determined two no longer qualified to be 
included in my sample due to their type of HPV. Both of those original participants had HPV that manifested as skin 
warts on the hands and feet – a condition that is not considered a sexually transmitted infection and is not related 
to reproductive issues or cancers. Therefore, the numbers next to each quote coincide with the participants’ 
original interview number (1-25).  
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1.4 CURRENT STUDY 
Past HPV research has mainly focused on knowledge, awareness, and attitudes regarding the 
illness and vaccine (see: Constantine and Jerman 2007, Dempsey et al. 2006, Gerend and Magloire 2008, 
Holcomb et al. 2004, Pruitt et al. 2005). Research that has centered on women’s experiences related to 
STIs is often related to genital herpes (see: Lee and Craft 2002), or a multitude of STIs including HPV, 
genital herpes, and chlamydia (see East et al. 2012, Nack 2000). Major HPV-specific research studies 
have been conducted outside of the United States (see: McCaffery et al. 2004, McCaffery et al. 2006, 
Waller et al. 2007a) and are often survey based (see: McCaffery et al. 2004, Waller et al. 2007a). Due to 
the fact that the CDC recommendation of the HPV vaccine was fairly recent, past research on HPV (see: 
Nack 2002, Nack 2008, Perrin et al. 2006) did not analyze women’s lived experience in relation to the 
vaccine. More recent scholarship related to HPV has instead focused on the influence of social support 
for Women with HPV (see: Kosenko et al. 2012).  
The current study adds to the field of research by exploring the lived experience of individuals 
who have been diagnosed with HPV through semi-structured interviews. Through detailed accounts of 
individuals’ experiences with having HPV, I was able to analyze how individuals with HPV felt about 
themselves, what they knew about their diagnosis, who they told, and how it impacted their sexual 
behavior. This work contributes to existing research on HPV in the United States and adds to current 
research on health literacy, patient-provider communication, and STI prevention.  
The following chapters highlight the process from diagnosis to post-diagnosis emotional state to 
disclosure to friends, family, and sexual partners to sexual behavior choices post-diagnosis. A major 
theme throughout these chapters is HPV knowledge. Many individuals with HPV who were misinformed 
about HPV prevalence, transmission, consequences for partners, clearance and dormancy experienced 
undue stress, internalized stigma, put themselves at risk for re-infection and put their sex partners at 
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risk for contracting HPV. As I posit in the following chapters, informative, emotionally supportive doctors 
play a vital role in educating individuals at diagnosis and the general public on basic facts related to HPV. 
  
 12 
2 “They Just Railroaded Past It Like It Was Not a Big Deal”: How Providers Impact Patient HPV 
Knowledge and Experience 
2.1 ABSTRACT 
Human Papillomavirus (HPV) is the most prevalent sexually transmitted infection in the United 
States, however, health literacy around HPV is relatively low. Many individuals are misinformed about 
key aspects of HPV. This study uses in-person, semi-structured interviews to examine HPV knowledge 
among those with HPV. It also analyzes how this knowledge impacted individuals’ emotional state upon 
diagnosis. The study found that post-diagnosis many individuals were ill-informed about HPV 
transmission, dormancy, prevalence, clearance, and association with cervical cancer. These findings 
suggest that practitioners’ messages about HPV are inadequate and more work is needed to facilitate 
effective and empathetic patient-provider communication. 
 
2.2 INTRODUCTION 
Human Papillomavirus (HPV) is transmitted most commonly through sexual contact, such as 
vaginal, anal, oral sex, and intimate skin-to-skin contact (Moscicki 2005). It is the most prevalent sexually 
transmitted infection in the U.S. (CDC 2017a). According to 2016 data, nearly 79 million Americans are 
infected with HPV, with 14 million becoming newly infected annually (CDC 2017a). Although increased 
incidence of HPV has long been associated with greater number of sexual partners and “risky” sexual 
behavior (e.g., multiple partners, unprotected sex), according to recent data, many women acquire HPV 
within the first few months (2.6 month median) of their first sexual relationship (Collins et al. 2002). In 
fact, Collins et al. suggest that “perhaps cervical human papillomavirus infection should now be 
considered an inevitable consequence of sexual activity” (2002:98). Despite heightened vaccine 
messaging (Abdelmutti and Hoffman-Goetz 2009; Mamo et al. 2010), 32% of Americans have never 
heard of HPV; 31% have never heard of the HPV vaccine; nearly 38% are unsure or do not know that 
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HPV causes cervical cancer; 43% do not know that HPV was a sexually transmitted infection; and 95% do 
not know that HPV often clears3 from the body without treatment (Blake et al. 2015).  
Over the past few decades, the United States health care system has transitioned. Previously, 
patients were passive participants, now they are encouraged to be active and informed health care 
consumers (Parker 2010, Street & Epstein 2008). Despite the health care industry’s promotion of patient 
empowerment, misinformation and misunderstanding are common, therefore researchers and health 
practitioners “must pay attention to how patients access, understand, and use health information 
provided to them to promote, protect, and manage their health” (Parker 2010:29). Health literacy is the 
“degree to which an individual has the capacity to obtain, communicate, process, and understand basic 
health information and services to make appropriate health decisions” (CDC 2016b: n.p.). Patient health 
literacy skills include: finding health information and services, communicating their needs, processing 
meanings of information, understanding choices and consequences, and deciding what services meet 
their need (CDC 2016b). Provider health literacy skills include: helping patients find information and 
services, communicating about health and healthcare, process patient questions and preferences, 
understanding how to provide useful information, and deciding what information and services are best 
for specific situations (CDC 2016b). Health literacy is a basic tenet of public health promotion and a 
critical effort of the United States Department of Health and Human Services (U.S. Dept. of Health and 
Human Services 2010).  
Level of HPV health literacy is often related to age, gender, socioeconomic status and race 
(Kutner 2006). Americans, aged under 65 are more likely to have heard of HPV, the vaccine, and to know 
that HPV can cause cervical cancer, compared to Americans over the age of 65 (Blake et al. 2015). White 
women are more likely to be aware of HPV and the vaccine, have greater knowledge of HPV, and to 
have been diagnosed with HPV, compared to women of other racial and ethnic groups (Blake et al. 2015; 
                                                 
3 According to research, HPV often clears from the body because of the host’s immune response (Moscicki et al. 
2006). Most HPV infections clear within 2 years (CDC 2013).   
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Gerend and Shepherd 2011; Jain et al. 2009; Reimer et al. 2014; Tiro et al. 2007). HPV health literacy, 
specifically awareness of and knowledge about HPV, is positively associated with level of education 
(Blake et al. 2015; Holcomb et al. 2004; Jain et al. 2009; Pruitt et al. 2005; Tiro et al. 2007). Americans 
with a college education are more likely than those with a high school degree to have heard of HPV and 
the HPV vaccine, to know the link between HPV and cervical cancer, and to know that HPV is a sexually 
transmitted infection (Blake et al. 2015). While many college students are knowledgeable about HPV’s 
link to cervical cancer, they tend to be unaware of the link to genital warts; that HPV can be transmitted 
skin-to-skin; that HPV is transient in nature and can resolve on its own; that HPV is highly prevalent; and 
that most women with HPV will never develop cervical cancer (Gerend and Magloire 2008; Sandfort and 
Pleasant 2009). College students also often do not perceive themselves as at risk for HPV (Gerend and 
Magloire 2008). A more recent study on a racially and ethnically diverse group of women college 
students found both vaccinated and non-vaccinated women are unaware of the disease’s prevalence, 
risks of transmitting HPV, and that HPV can cause genital warts (Ratanasiripong et al. 2013).  
2.3 THEORY 
2.3.1 Doctor Communication Regarding HPV 
Researchers have analyzed patient-provider interactions since the 1950s. These interactions 
range from the paternalistic model of the 1950s, where the patient was a passive actor and the doctor 
maintained control, to the 1970s’ consumerist model, where patients exercised greater control than 
their doctors (Street & Epstein 2008). Recent research indicates that patients prefer their relationship 
with their doctor to be one with mutual trust, respect, and engagement (Fuertes et al 2007; Fuertes et 
al. 2016). They prefer to have providers who are informative, emotionally supportive, empathetic, 
respectful, competent, and pleasant (Aelbrecht et al. 2014; Mazzi et al. 2015). Individuals who feel they 
have a strong relationship with their doctor, compared to those who do not, can have improved health 
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because they are more satisfied, more likely to heed doctors’ recommendations, and are more 
committed to treatment plans (Fuertes et al 2007).  
Squier developed the model of “empathetic understanding,” in which he posited that doctors 
could better understand health problems through open communication and labeling of feelings and 
sensations (Street & Epstein 2008). However, doctors are not often comfortable discussing patients’ 
distress because emotional detachment to patients is favored in the Western medical field (Kerasidou 
and Horn 2016). Additionally, some patients refrain from expressing emotion upon diagnosis of a 
potentially life-threatening disease, which can lead to heightened anxiety and depression (Iwamitsu et 
al. 2003). According to researchers, encouraging patients’ emotional expression at diagnosis, being 
reassuring, clearly communicating disease-specific information, and answering patients’ questions the 
same day can give patients a better sense of control and diminish their distress (Iwamitsu et al 2003; 
Schofield et al. 2003).  
In-depth interview analysis demonstrates that general practitioners and nurse practitioners do 
not widely discuss HPV with their women patients (McSherry et al. 2012). Research suggests that among 
women receiving routine Papanicolaou (Pap) tests, rarely do doctors discuss the topic of HPV (Cermak, 
et al. 2010). In fact, women often report that their doctors neglected to mention HPV associated risks, 
HPV prevention, and the HPV vaccine during their Pap test appointments (Cermak, et al. 2010). Women 
undergoing routine Pap tests rarely demonstrate an understanding of why the test is being performed 
and what normal and abnormal results indicate (Mays et al. 2000).  
Most women diagnosed with HPV are informed by their clinical staff by phone, letter, or email 
(Harvey-Knowles and Kosenko 2012; McCree et al. 2010). They tend to have many unanswered 
questions about their diagnosis, because of the impersonal ways in which they news is delivered 
(Harvey-Knowles and Kosenko 2012). Researchers posit that most women do not fully understand HPV 
upon initial diagnosis (Bertram and Magnussen 2008; Kosenko et al. 2014). Upon initial diagnosis, 
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women are often shocked and lack the mental clarity to ask their doctor details about HPV (Kosenko et 
al. 2014). Patients may express embarrassment, fear, confusion, anger, and concern about cancer and 
fertility (Daley et al. 2008; Diaz 2013; Nack 2008). Upon diagnosis, women with HPV may feel “dirty,” 
“gross,” or “unclean” (East et al. 2012:17; Nack 2008:66). They are often confused about the symptoms, 
impact on fertility, treatment options, recommended lifestyle changes, impact on male sexual partners, 
and how HPV differs from other STIs (Bertram and Magnussen 2008; Perrin et al. 2006).  
Post-diagnosis surveys conducted across four states indicate that women are incorrect or 
unsure about: how many types of HPV exist; that it is not a sex-specific infection; that a vaccine can 
prevent it; and that it is transient in nature and can clear (McCree et al. 2010). Research also indicates 
that women with HPV often lack knowledge about the sexual transmission and high prevalence of HPV 
(Barnack-Tavlaris et al. 2016; Bertram and Magnussen 2008; Sharpe et al. 2006). Other misconceptions 
about HPV, among women with HPV, are that it is a bacterial infection similar to a yeast infection or that 
it is a permanent illness (Barnack-Tavlaris et al. 2016; Bertram and Magnussen 2008; Daley et al. 2008). 
Women with HPV often understand that there is an association between abnormal Pap test results and 
cancer (Tiro et al. 2007; Sharpe et al. 2006), although few specify cervical cancer (Sharpe et al. 2006). 
They are less likely to associate abnormal Pap tests with HPV (Sharpe et al. 2006). Prior to HPV+ 
diagnosis, many women with abnormal Pap tests report little concern about their health at the time of 
their first abnormal Pap test (Sharpe et al. 2006). These women often are unsure or incorrect about 
which type of HPV they have, and often confuse low-risk HPV with high-risk HPV (Bertram and 
Magnussen 2008; Daley et al. 2008).  
Women often report that they receive confusing information from their doctors at time of 
diagnosis, formulate new questions after leaving the doctor’s office, and are too upset at time of 
diagnosis to understand their doctor (Daley et al. 2008). Women often seek out HPV information online 
post-diagnosis (Harvey-Knowles and Kosenko 2012). Women who are diagnosed with HPV and are then 
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scheduled to have a colposcopy4 also lack knowledge about the infection’s transmission, treatment, 
symptoms, and association with cervical cancer (Pruitt et al. 2005). Women with HPV have 
recommended, in a research study, that doctors discuss the prevalence of HPV and do not solely focus 
on discussing their condition as potentially cancerous (Bertram and Magnussen 2008).  
When given educational materials on HPV, women are less likely to feel anxious about testing 
and be less concerned if they test positive, compared to before reviewing the educational materials 
(Papa et al. 2009). Despite some reports of helpful and communicative doctors, women recently 
diagnosed with HPV often lack information about the infection (Bertram and Magnussen 2008; Kosenko 
et al. 2014; Perrin et al. 2006; Sharpe et al. 2006). This lack of knowledge often occurred when health 
care providers used excessive medical jargon, allocated insufficient time to explain the diagnosis, 
seemed insensitive to their patients, and lacked an established patient-provider relationship (Bertram 
and Magnussen 2008).  
 
2.4 CURRENT STUDY 
Due to the fact that many individuals are still unaware of HPV, its link to cervical cancer, and the 
HPV vaccine, researchers highlight the need for effective patient-provider communication about this 
topic (Blake et al. 2015; Smith et al. 2015). Through my research, I sought to discover whether 
individuals with HPV were knowledgeable about the infection prior to and after their own diagnosis and 
how their knowledge of HPV influenced their feelings upon diagnosis. 
Due to health practitioners’ noted poor communication about the STI, I sought to discover 
whether individuals diagnosed with HPV were knowledgeable about the infection prior to and after 
                                                 
4 A colposcopy is often recommended after an abnormal pap result. During this procedure, a health care provider 
examines the cervix through a colposcope and, if need be, performs a biopsy of the cervix for laboratory testing 
(Johns Hopkins n.d.).  
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diagnosis. Through my research, I also sought to understand how those diagnosed with HPV felt about 
themselves after diagnosis and how their knowledge of HPV influenced these feelings.  
 
2.5 METHODS 
 I recruited my participants via advertisements (flyers) displayed and distributed at the 
recruitment facilities. This discreet recruitment method is commonly used among STI researchers in 
order to avoid embarrassment of participants (see: Kosenko et al. 2012; East et al. 2012). Multiple 
versions of the flyer were disseminated with various photos of young girls and women from different 
racial and ethnic groups on them in order to appeal to a diverse group of potential participants. Each 
flyer contained tear-off tabs so that interested parties could easily obtain my contact information. 
Additionally, each flyer included a Quick Response code. Quick Response codes are an increasingly 
popular advertisement tool that can be scanned and read by smartphones (Shin, Jung, and Chang 2012). 
The flyers contained a unique Quick Response code that linked smartphone users to my online eligibility 
form. This eligibility form required users to enter their age and HPV status and then, if eligible and 
interested in participating, their contact information was automatically sent to me.  
Due to the fact that individuals with STIs qualify as a hard-to-reach population and recruitment 
can be difficult (Dixon-Woods et al. 2001; Nack 2008), I employed purposive, facility-based sampling and 
snowball sampling. I utilized key locations to find study participants (Magnani et al. 2005), such the 
health clinic at a large public university in the Southeastern United States and multiple privately-
operated gynecological clinics around a large metropolitan area in the Southeastern United States. 
Commonly cited barriers to STI screenings include cost, privacy, language barriers, and perceived 
discrimination at the clinical site (Tilson et al. 2004). Therefore, I chose to include clinics that offer free 
or low-cost STI screening services to English and non-English speakers and that abide by anti—
discrimination laws specific to patient admission and treatment. I also posted flyers around two major 
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universities, high-traffic pedestrian areas, and throughout diverse neighborhoods. Additionally, I gained 
entry into online support groups for individuals with HPV5 to recruit group members for my study. In 
order to allow for fully informed consent on the part of my subjects, I included accurate and 
straightforward information about my research and its purposes. 
 
2.5.1 Sample Demographics 
I gave all of my participants pseudonyms to protect their identity. My participants included 23 
women of various ages6. Six were in their 20s, eleven in their 30s, three in their 40s, two in their 50s, 
and one over 60 years old. Age at diagnosis varied with three receiving there HPV diagnosis at age 19, 
seven receiving it in their early 20s, six in their late 20s, three in their early 30s, one at age 45, and one 
at age 60. Sixteen of the 23 participants grew up in a two-parent family, three had a single parent, three 
had divorced parents and stepparents in the home, and one had divorced parents that never remarried. 
Twelve of my participants grew up in the Southeastern United States. Six of my participants grew up in 
the Northeast, three grew up in the Midwest, and two grew up outside of the United States. My sample 
was a highly educated group, with 10 of my participants having obtained a graduate degree, four in 
graduate school at the time of interview, six obtaining a terminal Bachelor’s degree, one currently in 
undergraduate school at the time of interview, one having had some college education, and one having 
a GED as highest level of education. Regarding occupation, eight worked in health and medicine, four in 
education, three in law, three in the arts, one in business administration, one in marketing, one in 
plumbing/engineering, and two as current students. The majority of my participants (73.9%) were white, 
                                                 
5 http://www.dailystrength.org/c/HPV/support-group; http://hpvsupport.com/phpBB3/; 
http://www.mdjunction.com/hpv; http://hpv.supportgroups.com/; http://www.hpvhope.com/support.html;  
6 My sample originally included 25 individuals, but after the interview, I determined two no longer qualified to be 
included in my sample due to their type of HPV. Both of those original participants had HPV that manifested as skin 
warts on the hands and feet – a condition that is not considered a sexually transmitted infection and is not related 
to reproductive issues or cancers. Therefore, the numbers next to each quote coincide with the participants’ 
original interview number (1-25).  
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21.7% were black, and 4.35% were multiracial. Ten of my participants were single at the time of 
interview, 8 were in a committed relationship, and 5 were legally married. In terms of gender identity, 
22 of my participants identified as women and one identified as gender queer. In terms of sexual 
orientation, 18 classified themselves as heterosexual, one as lesbian, and four as bisexual. Fifteen of the 
participants resided in the Southeastern U.S. at the time of their interviews, and three lived in the 
Northeast, one in the Southwest, two in the West, and two outside of the United States.  
 
 
 
2.5.2 Interview Method 
 
 Although many past researchers have used surveys to analyze knowledge, awareness, 
and attitudes regarding HPV and the vaccine, other researchers find that semi-structured interviews 
allow participants to demonstrate meanings attached to their STI diagnosis and personal experiences of 
dealing with this new diagnosis (see: Gerend and Magloire 2008; Lee and Craft 2002). Interviews of 
HPV+ participants, compared to survey research, are more likely to foster discussion of actual lived 
experiences related to diagnosis and living with HPV.  
 As a feminist interviewer, I was cognizant of my role as a researcher and my potential 
source of authority during the interview process (Hesse-Biber 2007). In order to diminish the 
hierarchical relationship between researcher and participants, after each interview, I shared relevant 
aspects of my own biography (Hesse-Biber 2007) and experience with HPV. I strove to be reflexive and 
to consider how my biography, values, and attitudes influenced the research process (DeVault and Gross 
2012; Hesse-Biber 2007). As a woman with HPV, throughout the interview and analysis stages, I 
reflected on how my attitudes regarding the disease impacted my choice of interview questions and my 
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interpretation of participants’ responses (DeVault and Gross 2012). For example, my experience with a 
non-empathetic, uninformative doctor motivated me to ask about doctor-patient interactions and 
helped me understand the participants’ frustrations with similar experiences.  
Interview topics included: how participants felt upon initial diagnosis of HPV, what information 
they knew about HPV and the vaccine prior to diagnosis, what information they were given or sought 
out about HPV after diagnosis, how their diagnosis impacted them, and how they felt about themselves 
post-diagnosis.  
 
2.5.3 Analysis 
I conducted, recorded, and transcribed all of the interviews. I imported all transcribed materials 
into NVivo and analyzed using a grounded theory approach. I chose this analytic method because it is 
well suited for understanding social processes not yet commonly researched (Milliken 2010). And, as 
noted above, there have been very few qualitative studies on the lived experiences of individuals with 
HPV. From my transcription and pre-analysis coding, I identified a few themes that I wanted to further 
investigate related to patient-provider relationships: “patient- provider communication,” “HPV,” and 
“HPV vaccine.” I analyzed the transcripts using the triadic coding scheme of open, axial, and selective 
coding (LaRossa 2005). During open coding, I identified major themes related to patient-provider 
relationships, emotional response to diagnosis, and HPV knowledge, and deciphered what each concept 
represented (Lofland et al. 2005; LaRossa 2005). Most participants discussed how they received their 
diagnosis and what information their doctor did or did not provide them with at diagnosis. In the 
context of their diagnosis, each participant mentioned what they knew about HPV and how they felt 
upon initial diagnosis. I then reviewed the concepts for similarities and variations, assigned them to 
categories, and identified the most salient categories (Corbin and Strauss 1990). I analyzed patient-
provider communication to determine whether or not the doctors were generally informative, 
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supportive, and accessible to their patients. I then examined possible relationships between having an 
empathetic doctor and one’s experience with the diagnosis of a sexually transmitted infection. I also 
analyzed participant HPV knowledge pre- and post-diagnosis to determine what information each one 
learned after they were diagnosed with the STI. Finally, I analyzed the participants’ emotional responses 
to diagnosis (to determine if they were upset, unsuspecting, or seemingly unaffected by their positive 
status) and feelings about themselves post-diagnosis. In the axial coding stage, I analyzed the categories 
to determine how and why they differed among the participants, by focusing on the context, strategies, 
and consequences associated with each category (Corbin and Strauss 1990; LaRossa 2005). I analyzed 
relationships between HPV knowledge post-diagnosis and patient-provider communication. I also 
analyzed the relationship between HPV knowledge post-diagnosis and participants’ emotional response 
to the diagnosis and how they learned about diagnosis. Finally, I moved on to the selective coding stage 
of my analysis, where I decided which categories were most representative of the central argument of 
my analysis (Corbin and Strauss 1990; LaRossa 2005). I found the relationships of post-diagnosis 
knowledge, how participant was diagnosed, and their emotional response to diagnosis to be most 
informative and related to patient-provider communication. 
 
 
2.6 FINDINGS 
2.6.1 Pre-Diagnosis Knowledge 
I looked at the impact informative doctors made on their patients’ knowledge of HPV. In order 
to access what knowledge each participant gained from their interactions with their doctor, I had to 
evaluate what information they knew about HPV prior to their diagnosis. Thirteen of the participants 
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already knew basic facts7 about the STI. Six of these individuals knew HPV was medically related to 
cancer. One of those participants felt that she would avoid the “really really scary stuff” (Amber) like 
cervical cancer because she had been vaccinated against HPV, while another noted that her knowledge 
of the link between cancer and HPV also came from vaccine messaging, stating: “I think I knew of it 
mostly through the vaccine advertisements. It was something that could cause cancer -- but maybe not 
necessarily -- and that there was a vaccine for it, but I had never considered getting it” (Erica). Seven of 
the individuals already knew that HPV was highly prevalent before their diagnosis. Most of those 
recalled not being scared or upset about their diagnosis because they knew how common HPV was in 
the United States. One participant learned about the prevalence because she had a friend diagnosed 
earlier and had researched the topic. She said: “I … found out that 90% of women have it at one point in 
their life whether or not they are aware of it” (Amber). Six participants explicitly stated that they were 
aware that HPV was a sexually transmitted infection before discussing their status with their doctor. 
Only two of the  participants knew all of these basic HPV facts, four more knew two out of three of these 
facts.  
Eleven participants were unaware of HPV prevalence, sexual transmission, and cancer 
consequences before their diagnosis. Five participants recalled having no knowledge of HPV pre-
diagnosis, revealing: “I didn't know anything about it when I was diagnosed (Emily)” and “I hadn't even 
heard of HPV at that time” (Andrea). Two of these participants researched the STI after visiting their 
doctor and learning they were HPV positive. One maintained that she “did not feel like she [the nurse] 
knew much … so I looked it up myself when I got to the car… right away.” (Janelle) Researching HPV, 
however, sometimes caused more anxiety about their diagnosis. For example, one woman, who already 
knew HPV basics before diagnosis said: “I looked up stuff on the internet which is always terrifying. I 
                                                 
7 Basic HPV facts, based on past research (Gerend and Shepherd 2011; Sandfort and Pleasant 2009 ), include (1) 
genital HPV infection can cause cancer (2) most genital infections clear up on their own (3) most individuals with 
HPV are asymptomatic (4) HPV is very prevalent (5) HPV can be transmitted by skin-to-skin contact. 
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think I tried to skip WebMD and went to the Mayo clinic… something a little more reliable, but it was 
still, like, this causes cancer and you will die…. That is not what I want to hear” (Erica).  
 
2.6.2 Post-Diagnosis Knowledge 
Post-diagnosis, nineteen participants knew about prevalence, transmission, dormancy, clearing, 
or risk associated with HPV post-diagnosis. The most frequently cited HPV facts were related to 
prevalence of the STI. Fifteen participants discussed the high prevalence of HPV. Three of them received 
this information upon initial diagnosis (e.g.: “My gynecologist said it was really not that big of a deal so 
really don't worry about it... ‘cause 1 in 5 people has it.” [Emily, diagnosed at age 19]), while others 
attributed their knowledge to the Garadasil commercials: “I knew more about what was going on… the 
prevalence… at that point there were already commercials and stuff for the vaccine which was out by 
then (Ashley, diagnosed at age 19).” Two individuals acquired their knowledge of HPV prevalence from 
studying the subject: “I have worked in sexual health since, like, 1989 so you know.... I understand that 
98% of the world has it (Colleen, diagnosed at age 38)” and “I know a lot about it because I formally 
studied reproductive health ... at a conference I went to a presenter said that HPV was biomarker of 
sexual activity for our generation (Phoebe, diagnosed at age 20).”  Most of these individuals simply 
conveyed that they knew it was common or that a “fairly significant proportion of the population has 
HPV (Leah, diagnosed at age 22)” and this oftentimes made them feel like their diagnosis was less 
worrisome: “Everybody has it. I am just one of everybody (Colleen, diagnosed at age 38).” However, 
knowledge about prevalence did not alleviate everyone’s worry about the diagnosis, as one participant 
stated: “you know, I judge myself…. I should have been more assertive about using condoms….I know it 
[HPV] is really common but I just have a different standard for myself I guess (Whitney, diagnosed at age 
45).” One individual felt that her doctor’s message about prevalence was both beneficial and 
detrimental: “I think it makes people feel less stigmatized. I think it matters how it is said. Talking about 
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the prevalence is different than saying, ‘oh, everyone has it and it is not a problem.” Just because 
something is prevalent does not mean it is not a problem or that it does not have negative 
consequences (Candace, diagnosed at age 19).”  
As stated above, participants also demonstrated knowledge of HPV related to transmission, 
dormancy, and clearing. Four individuals explicitly stated that HPV could be transmitted from skin-to-
skin contact, did not require penetrative sex, and that condoms would not completely protect a person 
from contracting it. According to two of these participants: “There is no 100% and I think it is a false 
sense of security people do get from using condoms (Riley, diagnosed at age 20)” and “People probably 
don't know that HPV is transmitted by skin-to-skin contact, and you can use condoms but it is not just 
about covering an orifice. You would have to have sex with a rubber suit on (Colleen, diagnosed at age 
38).” One participant explained that this information came from her doctor upon diagnosis: “She 
mentioned that the protection of a condom does not always work (Ava, diagnosed at age 22).” Another 
individual may have been misinformed by her doctor who told her that “it was sexually transmitted and 
I could pass it from cervical to penile contact … that was it (Tiffany, diagnosed at age 31).” Four 
participants mentioned that HPV can lie dormant in your body for a period of time. Specifically, they 
mentioned: “HPV can come up years after you've had a relationship with someone (Amber, diagnosed at 
age 25)”. A different participant actually felt misinformed by her doctor when she found “things [that] 
conflicted with what my doctor said…. She was very sure I had gotten it from my current partner and ... 
research I did online said it could be dormant (Ava, diagnosed at age 22).” Only two participants stated 
that their doctor told them that HPV could clear from a person’s body: “I had HPV and then I had normal 
Paps since, and my doctor said that my body must have cleared it - that was the language that he used 
(Candace, diagnosed at age 19)” and the doctor “said it is really common; your body will probably clear 
it in a couple of years (Carla, diagnosed at age 32).” Two other participants learned about clearance on 
their own; one knew about it only after no longer having HPV: “everything after that was fine. They 
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never needed to do anything else after…. I think it was just that I am fine... because I had HPV... it 
cleared out of my system I want to say within 2 years…. Then I was tested for my yearly the next year. I 
was clear of everything and I thought that was weird, but I came to find out that it can come and go out 
of your system [clear]. (Ashley, diagnosed at age 19).”  
 Eight participants mentioned their knowledge about developing cancer from HPV. Some 
of these individuals learned that HPV was related to cancer directly from their doctors: “the second 
diagnosis, when it was pre-cancerous… I believe they said ‘cervical’... the second time…. My only 
concern was if I was going to develop cancer (Leslie, diagnosed at age 22)” and “I just wanted to know if 
it [biopsy] would come back as anything…, like, anything important that was going to be leading to 
cancer.... That was my biggest concern (Ashley, diagnosed at age 19).” Two participants actually referred 
to their diagnosis as “pre-cancer (Leah, diagnosed at age 22).” Three learned this information from the 
Gardasil marketing campaign: “Now that I have it I think about cervical cancer ... only because the 
commercials are, like, if you have HPV you are more likely to get cervical cancer (Emily, diagnosed at age 
19)” and “I think I knew of it mostly through the vaccine advertisements. It was something that could 
cause cancer but maybe not necessarily and that there was a vaccine for it (Erica, diagnosed at age 26)”. 
Another individual said: “I read a statistic that, like, 90% of cervical cancer is caused by HPV even though 
most HPV is perfectly harmless. And reading that for the first time was like, oh I have this thing that 
basically you don't get cervical cancer if you don't have [it] (Phoebe, diagnosed at age 20).” One 
participant knew about the link between HPV and cancer, but stated that she was more concerned with 
infertility as a consequence of the STI: “from what I read the odds of developing cancer are relatively 
small, but after having the Loop Electrosurgical Excision Procedure (LEEP)8, the odds of having a 
complication from that are small, but something about that was scary to me. Anything that impacts 
                                                 
8 With LEEP, an electric current heated wire loop removes abnormal cells and tissues in the cervix and vagina. The 
tissue is then sent to a lab for testing. LEEP is often performed in order to detect cancer of the cervix or vagina 
(Johns Hopkins n.d.). 
 27 
fertility to me is, like, oh.... I don't know why that is scarier than cancer... but something about it made it 
really serious to me (Candace, diagnosed at age 19).”  
 
2.6.3 Comparing Pre- and Post-Diagnosis Knowledge 
Although almost all of the participants were informed about at least one aspect of HPV after 
their diagnosis, many were not fully informed. Nineteen of the 23 participants remained unaware of the 
fact that HPV can lie dormant in a human body for many years and 19 did not know that the body can 
clear HPV within a few years of contracting it. Among the individuals who knew about the body’s ability 
to clear HPV, only two learned this information from their doctor. Another participant who was aware of 
clearance learned this information by reading literature on HPV. Nineteen of the participants also did 
not know that HPV could be contracted through skin-to-skin contact and did not require penile-vaginal 
or penile-anal penetration. One of the 4 participants who knew about skin-to-skin transmission of HPV 
learned this information by working in the STI field, not from her doctor. One participant who knew 
about skin-to-skin transmission learned this directly from her doctor and the others were unsure where 
this information originally came from stating, “honestly my education may have come from commercials 
which is probably bad… but ... yeah it could have been a thing where my doctor mentioned it first… I 
don't really remember. I don't think I knew much about it until the time I was about to get the vaccine” 
(Carla, diagnosed at age 32).  Seven interviewees did not understand that HPV was linked to cancer in 
women. Among those who knew about the association between HPV and cancer, four learned this from 
their doctor, two learned this through online research, three learned this through the Gardasil 
campaign, and the rest were unsure about where they obtained this knowledge. Eight participants 
remained unaware of the high prevalence of HPV after their diagnosis. Among those who learned about 
the high prevalence of HPV post-diagnosis, three attributed this knowledge to their own research or the 
vaccine commercials, rather than their doctor.  
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2.6.4 Emotional Impact of Diagnosis 
Participants’ emotional responses upon initial HPV diagnosis demonstrate a range of responses, 
framed largely in terms of anxiety and worry or lack thereof. Five participants were ambivalent about 
their positive diagnosis. One stated: “I wasn't upset because, you know, what can I do about it?” (Carla). 
Another related her lack of anxiety surrounding diagnosis to her pre-diagnosis knowledge stating, “I 
must have known how common it was because I never got freaked out, really” (Phoebe).” One 
participant differentiated between cancer and HPV: “HPV's not really the problem - the problem is the 
cancer cells, so while I didn't worry about what was going on with that… I don't know, it didn't seem like 
something worth worrying about. Everybody has it, we will just have to deal with it” (Andrea). Another 
participant related her reaction to the diagnosis to her personality: “I just thought, it is what it is…. I am 
just the type of person…. I don't mope and groan about one thing because there is just so much more 
for me to have to worry about” (Tiffany). 
Nineteen participants, however, had negative feelings toward their diagnosis. Many of them felt 
anxious and scared upon diagnosis. One said: “I was stressed out. It was more confusing... everything 
else was fine on the day of my checkup... everything else was fine, I was good ... I NEVER expected to 
have an STI just because I play it safe and I haven't had many partners AT ALL. So I was upset. I felt that I 
was tainted unfairly” (Kendra). Another stated: “I felt scared ... yeah and nervous about it. There was a 
point when I was 20 or something when I had bumps, like, in my vulva and they really looked white and I 
got freaked out - I don't remember if that was before or after I found out I had the abnormal cells - but I 
remember being terrified by that ... terrified that I had something” (Candace). Other participants stated:  
I was concerned. There was nothing they could do… (Katherine),  
I was really upset... I cried... I was really afraid... (McKenzie), 
I mean I was initially scared and you know (Summer), 
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I was mortified... absolutely mortified (Ashley),  
I kind of just felt like I was broken (Kaylee),  
[I]s it that serious... how quickly can it become serious (Erica). 
[I]s it something that is going to kill me (Janelle). 
Some were caught off guard by their diagnosis. One participant stated: “I was really surprised to 
be honest” (Jessie). Another stated that she “had a shockingly late, surprising diagnosis… I don't 
understand how I have HPV now and I haven't for the majority of my life” (Colleen). Others were 
ashamed by their diagnosis; saying things like: “I felt dirty and I felt gross … I felt ugly and I did not feel 
sexually viable” (Emily), and “I feel ashamed I guess... you know, you are just dirty, kind of” (Whitney). 
Some participants felt that their positive HPV status was deserved because they had been “irresponsible 
with [my] body” (Amber) in the past or upon diagnosis they thought, “‘Holy Shit! what Bastard had it?’… 
I thought, in my own Roman Catholic upbringing as a child…, ‘oh, now I guess you paid for that piece of 
ass’” (Theresa). 
 
2.6.5 Emotional Impact of Diagnosis by Type of Diagnosis 
Five of the participants received word of their positive status from a nurse or clinic staff 
member, not their doctor. The participants who were informed by a nurse commonly felt their 
conversations were awkward. All of these participants had negative emotional reactions to their 
diagnosis. One participant, who felt ashamed and dirty upon diagnosis, stated: “It was weird because 
somebody called me on the phone that was not my regular gynecologist - she was on vacation- so this 
stranger called me up and told me about it” (Whitney). One participant who was shocked by her 
diagnosis recalled receiving this information over the phone stating: “So the nurse called and said, ‘We 
got your test results back and everything looks good, HPV came back positive,’ and she just RAN through 
it and I was, like, ‘what?’ and she was ‘your HPV is positive’ and I said ‘how is that possible, I am always 
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negative’…. So I said to the nurse, ‘no my doctor needs to call me back immediately and explain these 
test results’” (Colleen). Another participant who was very concerned about the seriousness of her 
diagnosis was told she was HPV+ as an afterthought by her clinic, “they were, like, ‘oh and by the way 
you have HPV sorry we did not call you, we forgot’.… I remember them botching the situation... they 
forgot to call me, if I had not called them I don't think they ever would have told me... unless I would 
have pursued getting whatever test redo and been, like, ‘hey what's going on’.... so I was really really 
unimpressed with how the whole thing was handled. I was, like, you know what I am going somewhere 
else” (Erica). Another participant who was mortified upon diagnosis, found out her status from a nurse 
in an abrupt manner: “the nurse or whoever was working was very abrupt and she was, like, ‘you have 
warts’ and I did not understand what was happening... so I then went and got tested for everything and 
she said I had HPV... so that was when I was technically diagnosed the first time” (Ashley). Another 
participant who was worried that HPV could lead to death stated: “I found out [that I had HPV] from my 
Pap test from my annual gynecological visit that I hate... the worst day of the year every year... she just.. 
it was kind of casual when she called me and told me ‘oh yeah you tested positive for that and 
everything else is good.’ I was, like, ‘whoa whoa lets back up to the tested positive for that’... it wasn't 
the doctor who told me, it was a nurse in the office and she just kind of railroaded past it like it is not a 
big deal, she acted like it was nothing” (Janelle). 
Four participants recalled finding out they had HPV and their doctors or clinical staff assumed 
they already knew because it was in their medical records. All of these participants experienced negative 
emotions upon HPV diagnosis. One participant felt ashamed about her diagnosis, but did not feel 
offended by this assumption stating: “Given my age [late 40’s], I think my doctor assumed I knew, so she 
called me up and was, like, ‘your pap was abnormal so we have to do this LEEP procedure.’ I was 
focusing on that and then she said and ‘you have HPV’” (Whitney). However, others recall being shocked 
by their doctor or nurse’s bluntness. One participant who described herself as “broken” when 
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diagnosed, recounts the negative exchange she had with her doctor: “He was, like, ‘well you do carry the 
Human Papillomavirus (HPV)’ and I was, like, ‘what? I did not know that I had that’ and he was, like, ‘yea 
you have had to have had it for a while’ …. I was, like, ‘I have been with the same person for 6 years … 
no one told me this’…I wish my doctor told me … it feels, like, they are definitely keeping it a secret. Like, 
the doctors are not telling us” (Kaylee). Another participant experienced a similar late diagnosis: “I did 
not find out that HPV was the cause of my dysplasia until many years later when I was digging through 
my medical records with my doctor after they told me my dysplasia was back... there is actually a 3 year 
long story of that.. so the dysplasia at 20 which they did a LEEP for was definitely HPV but I did not know 
that until years later which I was kind of pissed about …so I sat there with the nurse practitioner and my 
medical records and we went through it and I was, like, ‘tell me what the fuck is going on here’…. so 
they saw the old HPV results so there it was clear as day and piece of paper from when I was 20 years 
old saying HPV positive… so I am 33 now… so 13 years ago around they thought it was not important to 
tell you, you had HPV.. they knew it” (Riley). This particular participant felt so ill-informed by her earlier 
clinicians about HPV that she felt extreme anxiety from her condition stating: “I was, like, I am going to 
die of cancer… because I did not know it was a communicable virus that caused it I thought my body had 
manifested cancer at 20 years old” (Riley). 
 Another who said she was “scared” upon diagnosis found out she had HPV only after asking 
questions about her last abnormal Pap test, “No they CALLED me and said, ‘you have another abnormal 
pap smear’ and .... I was worried about getting the biopsy again because the first one was painful…. so I 
was, like, ‘is there any way we can do something else?’ And I was asking them all these questions and 
the woman was like... she said very bluntly something, like, ‘how long have you known you've had this 
disease?’ and I was just ‘what disease are you talking about’ and she told me and then I was at home 
and I did a bunch of research that day” (Summer). 
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Only three out of 23 participants felt supported by their doctors at diagnosis in such a way that 
they felt less emotional upheaval after discussing their diagnosis with their doctor. One participant 
reasoned that having confidence in her informative doctor possibly prevented her from having an 
emotional response to the diagnosis stating: “I don't really remember having a strong emotional 
response to it. I mean I was worried about it but I tended to have a good bit of faith in the medical 
profession. It’s kind of, like, ok this is cool this guy knows what's going on and what to do next and he's 
going to take care of it. It's not cancer yet so I think we are ok” (Leah).  
Two of the 23 participants who were upset upon initial diagnosis had their worries assuaged by 
the doctors. One of these participants stated that upon initial diagnosis: “I started crying. I was really 
upset because I was not really educated and did not know what it meant and then he [doctor] kind of 
calmed me down and explained. He gave me an education on it and I feel like that was pre-Googling 
everything” (Leslie). Another stated: “I was, like, panicking and crying and the doctor was, like, ‘oh no it 
is going to be ok’ …. She said it really is so common and a lot of people are affected by this and it is not 
going to harm you” (Ava).  
Some participants, however, could not be assuaged by their doctors’ attempts to emotionally 
support them. One participant stated, “when I found out about it I kind of just felt like I was broken... 
even though he told me that there are tons of women that have it and its nothing to be scared of. He 
told me I am not going to die from it or anything. It still made me feel like I wasn't a complete woman. 
Especially considering what he said [that]... the hysterectomy thing is next... it diminished my value... 
that's what it felt like” (Kaylee).” Another stated, “at the time I was kind of freaking out.... I was, like, oh 
my god I have an STD... that was an emotional crisis for me even though she told me it was very 
common ... it is not gonna hurt me at all in my future?.. I asked” (Ava).  
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2.7 LIMITATIONS 
Past qualitative research on HPV has relied on non-diverse samples of primarily white, college-
education women (see: Kosenko et al. 2012, Nack 2008). Although I sought to reveal the stories of a 
diverse sample based on ethnicity, race, and educational attainment level, my sample was more 
homogeneous than initially intended. My sample included cis-gender and gender non-conforming 
biological females from different racial and ethnic groups ranging in age. However, I was unable to 
include participants of varying levels of educational attainment. This may have been a result of my 
sampling method, however, I also believe it is due to the fact that women with lower socioeconomic 
status and less education are less likely to have regular gynecological appointments and routine Pap 
tests compared to their more educated peers (Behbakht et al. 2004; Katz and Hofer 1994). Without 
regular visits to the gynecologist and routine Papanicolaou tests, women are much less likely to know 
they are HPV positive. Therefore, individuals who saw my flyers may have thought they did not qualify 
because they did not know their positive status.  
Despite this limitation, my research adds knowledge to the field because of the rich detail my 
participants provided during their interviews. Many past researchers used surveys to analyze 
knowledge, awareness, and attitudes regarding HPV, but qualitative researchers have found that semi-
structured interviews allow participants to demonstrate meanings attached to their STI diagnosis and 
personal experiences of dealing with this new diagnosis (see: Gerend and Magloire 2008; Lee and Craft 
2002). My work differs from existing studies where researchers ask undiagnosed women how they 
would feel if they were diagnosed with HPV (see: Waller et al. 2007a). My interviews of HPV+ 
participants, however, fostered detailed discussion of actual lived experiences related to HPV diagnosis, 
HPV knowledge, emotional impact of diagnosis, and patient-provider communication.  
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2.8 DISCUSSION 
Numerous studies highlight the correlation between health literacy and health behaviors. 
Researchers have found that many cervical cancer prevention brochures are written at reading levels 
too difficult for most consumers (Helitzer 2012). Women under 40 years old with below-basic health 
literacy have a lower probability of having a Pap test than women in the same age group with proficient 
health literacy (Hanchate 2008). Individuals with higher health literacy levels have been found to have a 
greater understanding of cervical cancer and pap smears (Tiraki and Yilmaz 2017). They are also more 
likely to participate in prevention measures, such as Pap smears (Tiraki and Yilmaz 2017 ). 
Two decades ago, researchers found that individuals with HPV were dissatisfied with their 
health care providers’ handling of their diagnoses because their providers did not offer emotional 
support, provide written information on HPV, or refer them to a specialist (Clarke and Ebel 1996). 
Common barriers to discussing HPV for surgeons, clinical oncologists, and nurse specialists alike included 
lack of knowledge about the virus and not feeling well informed about HPV (Dodd et al. 2016). 
Researchers have discovered that practitioners’ non-discussion of HPV is influenced by a general lack of 
knowledge, a difficulty in keeping up-to-date on ever evolving HPV facts, and concern that information 
on HPV from pharmaceutical companies is biased (McSherry et al. 2012). They also cite patient-provider 
issues as barriers to this communication, including: concern that they will embarrass their patient and 
themselves; lack of a clear opening to facilitate discussion of HPV; difficulty explaining HPV to patient in 
terms they can understand; fear that their discussion of HPV would be viewed as judgmental; 
uncertainty of necessity to discuss potential transient infection with patient; and lack of time and 
discussion aids for consultations with patients (McSherry et al. 2012). Other communication barriers to 
HPV discussion include patient lack of knowledge or interest in the STI, and fear that women would not 
follow through with Pap tests once they knew more about HPV (McSherry et al. 2012). Many head and 
neck practitioners (who diagnosis individuals with high-risk HPV types linked to oropharyngeal 
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squamous cell carcinoma) say they worry about patients blaming themselves after diagnosis (Dodd et al. 
2016). Therefore, the practitioners try to assure their patients that they could not have done anything to 
prevent their diagnosis (Dodd et al. 2016). 
Researchers have suggested that practitioners’ messages about HPV are inadequate because 
there is a dearth of HPV knowledge among the general public; it is not often included in sexual 
education curriculum and those who are aware of HPV overestimate their risk of cancer (Warren and 
Ebel 2005). Effectively communicating about HPV without causing undue psychosocial stress requires 
skill and sensitivity on the part of the provider (Harper 2004). In fact, breaking bad news is cited as one 
of the most difficult aspects of being a medical service provider, yet doctors often lack adequate training 
in this area (Sparks et al. 2007). Therefore, practitioners must stay informed of the most current 
scientific data on HPV and be able to educate their patients on the subject in an empathetic manner 
(Diaz 2013). 
Many of my participants received their HPV diagnosis over the phone which supports the 
findings of past research (see Harvey-Knowles and Kosenko 2012; McCree et al. 2010). Doctors, 
however, are best able to offer emotional support and correctly answer patient questions when they 
diagnosis face-to-face (Harvey-Knowles and Kosenko 2012). Unsurprisingly, this method of diagnosis 
communication is most preferred among patients (Harvey-Knowles and Kosenko 2012). When receiving 
a diagnosis over the phone, patients often have many unanswered questions about HPV and how it will 
impact them (Harvey-Knowles and Kosenko 2012). 
According to past research, at diagnosis, some women recall experiencing supportive healthcare 
providers who gave information on HPV while providing reassurance (Bertram and Magnussen 2008). In 
my study, however, few participants cited having an empathetic, supportive, and informative doctor 
who diagnosed them. To minimize the psychological distress associated with a positive diagnosis, 
doctors should discuss abnormal results with their patients in a clear, concise, supportive manner (Diaz 
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2013). Doctors should also be mindful of the timing of their discussion and their patients’ health literacy 
level (Diaz 2013).  
Doctors should consider key messages that may minimize the negative consequences of HPV 
diagnosis such as: normalizing HPV by focusing on how it is easily transmitted through sexual activity, 
highlighting the high prevalence of HPV and perhaps even stating that it is as common as the flu, and 
reassuring patients that they do not need to modify their behavior because they did not cause their 
status (Dodd 2016). In my study, participants who were knowledgeable about the high prevalence of 
HPV were less worried when diagnosed. Only 15 of my 23 participants were aware of how common it 
was after diagnosis, however, and only 3 of those were informed of this fact when receiving their 
diagnosis.  
Post-diagnosis, many individuals are ill-informed about other important aspects of the disease. 
Only 8 participants in my study were aware of HPV’s link to cervical cancer after their own diagnosis. 
Over half of the participants who knew this information learned it from a source other than their doctor 
(Gardasil commercial or online). This is problematic because, without being informed by a doctor if their 
particular strain of HPV was linked to cancer, these participants could assume the worst and suffer from 
unnecessary stress.  I found that women were also rarely told about HPV’s tendencies to lay dormant in 
the body and clear after a few years. Some of my participants found out about clearance a while after 
being diagnosed with HPV (through their own research, from a new doctor) and felt relief at the 
prospect that they would not have HPV for a lifetime. Those who knew about HPV dormancy were less 
likely try to link their diagnosis to pat sexual experiences or partners. Doctors should, therefore, inform 
their patients, at time of diagnosis, about HPV dormancy and clearance in order to mitigate any feelings 
of blame on partners, self-blame, or pessimism. Very few participants were correctly informed about 
HPV transmission. Only four individuals stated that HPV could be transmitted from skin-to-skin contact 
and only one of these participants remembers that information coming from their doctor. It is a public 
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health issue that post-diagnosis, individuals are still misinformed about how this STI is transmitted. 
Without correct information on this topic, HPV positive individuals can do nothing to stop the spread of 
the disease.  
I found, in support of past research (see Bertram and Magnussen 2008; Kosenko et al. 2014; 
Perrin et al. 2006; Sharpe et al. 2006), that many individuals with HPV are misinformed about HPV. 
Based on my research, I recommend that healthcare practitioners strongly consider taking the time to 
have a face-to-face conversation with their patient when providing a positive HPV diagnosis. This may 
alleviate some patient confusion and any undue worry. Providers should also discuss with their patient 
the high prevalence of HPV at time of diagnosis. According to my research, which supports the findings 
of Bertram and Magnussen (2008), this discussion of prevalence is much appreciated by patients and 
can ease their minds upon initial diagnosis. Based on my findings, I also recommend that doctors make 
sure their patients are fully informed about key aspects of the disease: transmission, dormancy, 
clearance, and how, specifically, it is linked to cancer. 
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3 “She’s a Slut, She Has HPV”: HPV Stigma and Disclosure 
3.1 ABSTRACT 
Human Papillomavirus (HPV) is the most prevalent sexually transmitted infection in the United 
States, however, many Americans negatively view the disease and those infected with it. This study uses 
in-person, semi-structured interviews to examine feelings of stigma among individuals with HPV. It also 
analyzes how these feelings and HPV knowledge impacted individuals’ motivations to disclose their 
status to others. The study found that post-diagnosis many individuals were anxious and upset about 
their positive status and felt judged by some individuals in their lives. Confronting and internalizing this 
stigma, impacted how and why they disclosed and withheld their positive HPV status. These findings 
suggest that the culture around HPV needs to change so that individuals with a positive status no longer 
undergo undue stress and can openly educate others about the STI. 
 
3.2 INTRODUCTION 
Human Papillomavirus (HPV) is transmitted most commonly through sexual contact, such as 
intimate skin-to-skin contact, and vaginal, anal, and oral sex (Moscicki 2005). It is the most prevalent 
sexually transmitted infection in the U.S. (CDC 2017a). According to 2016 data, nearly 79 million 
Americans are infected with HPV, with 14 million becoming newly infected annually (CDC 2017a). 
Increased incidence of HPV has long been associated with greater number of sexual partners and “risky” 
sexual behavior (e.g., multiple partners, unprotected sex). However, according to recent longitudinal 
research, HPV detection, on average, occurs within 2.6 months of first intercourse (Collins et al. 2002). In 
fact, Collins et al. suggest that “perhaps cervical human papillomavirus infection should now be 
considered an inevitable consequence of sexual activity” (2002:98).  
Despite the high prevalence and easy transmission of this STI, many Americans negatively view 
the disease and those infected with it. Individuals with an STI often report disclosing their diagnosis 
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because keeping it secret interferes with their relationships with others (Lee and Craft 2002). By 
disclosing their condition, individuals with STIs can be reassured that they have not changed post-
diagnosis (Lee and Craft 2002). According to Lee and Craft, “through telling, the respondents get 
verification that they are still the same persons they were before genital herpes” (Lee and Craft 2002, 
286).  
Past research indicates that women feel more stigmatized and rejected socially when diagnosed 
with an STI, compared to men (Smith et al. 2007). Past research indicates that women are more likely 
than men to hide their STI diagnosis due to embarrassment (Smith et al. 2007). Additionally, women 
with STIs report internalizing their stigma and believing the stereotypes are true for them (East et al. 
2012). Women’s disproportionate stigmatization stems from historic blame of women as the vectors of 
sexually transmitted infections (East et al. 2012; Nack 2008).  
 
3.3 THEORY 
3.3.1 Stigma 
 
The symbolic interactionist approach, specifically Goffman’s theory on stigma is an appropriate 
framework through which to investigate the experience of living with HPV. According to Goffman, 
stigma is a less desirable attribute than one stereotypically assigned to persons of the same category 
(Goffman 1963:3). Stigmas can be related to character flaws, which are personality traits that deviate 
from those socially accepted or by physical deformities (Goffman 1963). Society views women who stray 
from the societal norms of female chastity and purity as deviant, morally corrupt, irresponsible, unclean, 
and promiscuous (East et al. 2012; Nack 2008). Therefore, they possess a character stigma (Nack 2008).  
When an individual’s dissimilarity is not obvious upon first meeting, they have a “discreditable 
stigma,” which can be hidden (Goffman 1963:42). They must determine what to tell or not tell and to 
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whom and when (Goffman 1963). According to symbolic interactionists, individuals incorporate others’ 
evaluations of them when self-evaluating (Nack 2008:65). Therefore, they may choose not to disclose 
their discreditable stigma, and instead, to hide it from others. Other discreditable persons, however, 
may reveal their shameful attribute to a few key individuals and then rely on those individuals for 
support (Goffman 1963). Alternatively, an individual can self-disclose and admit to having the stigma if 
they no longer feel the need to conceal it (Goffman 1963).  
Recent research on stigma also lends itself to this analysis. HPV stigma researchers that used the 
HIV Stigma Scale found that feelings of uncleanliness and disgust with oneself, categorized as negative 
self-image stigma, and fear of rejection, categorized as personalized stigma, were often felt by 
individuals with HPV (Barnack-Tavlaris et al. 2016). Attribution theorists suggest that individuals with 
illness that may be attributed to their behavior will face more judgement and stigma from others (Lebel 
and Devins 2008; Weiner, Perry and Magnusson 1988). As noted above, individuals with HPV are often 
seen as promiscuous and thus to blame for their sexually transmitted HPV (Nack 2008). 
  
3.4 CURRENT STUDY 
Research centered on individuals’ experiences of STI stigma is often related to genital herpes 
(see: Lee and Craft 2002), or a multitude of STIs including HPV, genital herpes, and chlamydia (see East 
et al. 2012, Nack 2000). Stigma related HPV research is often conducted outside of the United States 
(see: McCaffery et al. 2004, McCaffery et al. 2006, Waller et al. 2007a) and is survey based (see: 
McCaffery et al. 2004, Waller et al. 2007a). Through my research, I sought to discover how an HPV + 
status, a character stigma, influenced my participants’ feelings about themselves, and why they decided 
whether or not to disclose their status to family and friends.  
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3.5 METHODS 
Due to the fact that individuals with STIs qualify as a hard-to-reach population and recruitment 
can be difficult (Dixon-Woods et al. 2001; Nack 2008), I employed purposive, facility-based sampling and 
snowball sampling. I utilized key locations to find study participants (Magnani et al. 2005), such the 
health clinic at a large public university in the Southeastern United States and multiple privately-
operated gynecological clinics around a large metropolitan area in the Southeastern United States. 
Commonly cited barriers to STI screenings include cost, privacy, language barriers, and perceived 
discrimination at the clinical site (Tilson et al. 2004). Therefore, I chose to include clinics that offer free 
or low-cost STI screening services to English and non-English speakers and that abide by anti-
discrimination laws specific to patient admission and treatment. I also posted flyers around two major 
universities, high-traffic pedestrian areas, and throughout diverse neighborhoods. Additionally, I gained 
entry into online support groups for individuals with HPV9 to recruit group members for my study.  
I recruited my participants via advertisements (flyers) displayed and distributed at the recruitment 
facilities. This discreet recruitment method is commonly used among STI researchers (see: Kosenko et al. 
2012; East et al. 2012) so that interested parties can contact the researcher anonymously with any 
questions. Multiple versions of the flyer were distributed with various photos of young girls and women 
from different racial and ethnic groups on them in order to appeal to a diverse group of potential 
participants. Each flyer contained tear-off tabs so that interested parties could easily obtain my contact 
information. Additionally, each flyer included a Quick Response code. Quick Response codes are an 
increasingly popular advertisement tool that can be scanned and read by smartphones (Shin, Jung, and 
Chang 2012). The flyers contained a unique Quick Response code that linked smartphone users to my 
online eligibility form. This eligibility form required users to enter their age and HPV status and then, if 
eligible and interested in participating, their contact information was automatically sent to me.  
                                                 
9 http://www.dailystrength.org/c/HPV/support-group; http://hpvsupport.com/phpBB3/; 
http://www.mdjunction.com/hpv; http://hpv.supportgroups.com/; http://www.hpvhope.com/support.html;  
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3.5.1 Sample Demographics 
I gave all of my participants pseudonyms to protect their identity. My participants included 23 
women of various ages10. Six were in their 20s, eleven in their 30s, three in their 40s, two in their 50s, 
and one over 60 years old. Sixteen of the 23 participants grew up in a two-parent family; three had a 
single parent; three had divorced parents and stepparents in the home; and one had divorced parents 
that never remarried. Twelve of my participants grew up in the Southeastern United States. Six of my 
participants grew up in the Northeast; three grew up in the Midwest; and two grew up outside of the 
United States. Fifteen of the participants resided in the Southeastern U.S. at the time of their interviews 
with three living in the Northeast; one in the Southwest; two in the West; and two outside of the United 
States. My sample was a highly educated group, with 10 of my participants having obtained a graduate 
degree, four in graduate school at the time of interview, six obtaining a terminal Bachelor’s degree, one 
currently in undergraduate school at the time of interview, one having had some college education, and 
one having a GED as highest level of education. Regarding occupation, eight worked in health and 
medicine, four in education, three in law, three in the arts, one in business administration, one in 
marketing, one in plumbing/engineering, and two as current students. The majority of my participants 
were white (n=17, 73.9%), five (21.7%) were black, and one (4.35%) was multiracial. Ten of my 
participants were single at the time of interview, 8 were in a committed relationship, and 5 were legally 
married. In terms of gender identity, 22 of my participants identified as women and one identified as 
gender queer. In terms of sexual orientation, 18 classified themselves as heterosexual, one as lesbian, 
and four as bisexual.  
 
                                                 
10 My sample originally included 25 individuals, but after the interview, I determined that two no longer qualified 
to be included, due to their type of HPV. Both of those original participants had HPV that manifested as skin warts 
on the hands and feet – a condition that is not considered a sexually transmitted infection and is not related to 
reproductive issues or cancers. 
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3.5.2 Interview Method 
 
 Although many past researchers have used surveys to analyze knowledge, awareness, 
and attitudes regarding HPV and the vaccine, other researchers find that semi-structured interviews 
allow participants to explain their personal experiences of dealing with STI diagnosis and what this 
diagnosis meant to them (see: Gerend and Magloire 2008; Lee and Craft 2002). Interviews of HPV+ 
participants, compared to survey research, are more likely to foster discussion of actual lived 
experiences related to living with HPV and disclosure to others, and stigma. 
 As a feminist interviewer, I was cognizant of my role as a researcher and my potential 
source of authority during the interview process (Hesse-Biber 2007). In order to diminish the 
hierarchical relationship between researcher and participants, after each interview, I shared relevant 
aspects of my own biography (Hesse-Biber 2007) and experience with HPV. I strove to be reflexive and 
to consider how my biography, values, and attitudes influenced the research process (DeVault and Gross 
2012; Hesse-Biber 2007). As a woman with HPV, throughout the interview and analysis stages, I 
reflected on how my attitudes regarding the disease impacted my choice of interview questions and my 
interpretation of participants’ responses (DeVault and Gross 2012). For example, I was motivated to ask 
about disclosure to friends and family because of my own decision-making about disclosure. My 
personal experience also helped me understand the participants’ willingness or hesitation to tell others 
about their status.  
Interview topics included: how participants felt about themselves post-diagnosis, to whom they 
disclosed their status, and reasons for their disclosure and non-disclosure of status. 
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3.5.3 Analysis 
I conducted, recorded, and transcribed all of the interviews. I imported all transcribed materials 
into NVivo and analyzed them using a grounded theory approach. I chose this analytic method because 
it is well suited for understanding social processes not yet commonly researched (Milliken 2010). And, as 
noted above, there have been very few qualitative studies on the lived experiences of individuals with 
HPV. From my transcription and pre-analysis coding, I identified a few themes that I wanted to further 
investigate related to consequences of HPV: “stigma,” “disclosure,” and “initial impact of diagnosis”. I 
analyzed the transcripts using the triadic coding scheme of open, axial, and selective coding (LaRossa 
2005). During open coding, I identified major themes related to stigma, emotional response to diagnosis, 
and disclosure to friends and family, and deciphered what each concept represented (Lofland et al. 
2005; LaRossa 2005). In the context of their diagnosis, each participant mentioned how they felt about 
their diagnosis and who they told about it. I then reviewed the concepts for similarities and variations, 
assigned them to categories, and identified the most salient categories (Corbin and Strauss 1990). I 
analyzed consequences of HPV to determine how participants felt when first diagnosed, whether or not 
participants felt stigma due to their status, to whom and when they disclosed their status , and why they 
decided not to disclose their status to some individuals, if applicable.  
In the axial coding stage, I analyzed the categories to determine how and why they differed 
among the participants, by focusing on the context, strategies, and consequences associated with each 
category (Corbin and Strauss 1990; LaRossa 2005). I analyzed relationships between participants’ 
experience with the diagnosis, stigma, and disclosure.  Finally, I moved on to the selective coding stage 
of my analysis, where I decided which categories were most representative of the central argument of 
my analysis (Corbin and Strauss 1990; LaRossa 2005). I found the relationship between stigma and 
disclosure to friends and family to be most informative in this study.  
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3.6 FINDINGS 
3.6.1 Stigma 
3.6.1.1 Participants Who Felt Little to No Stigma  
Nine participants felt little to no stigma associated with their HPV status. One stated, “since 
everybody has it, I feel like it is a bacteria that lives in everyone. I don't think it has any stigma the way 
HIV has stigma” (Andrea). A few individuals mentioned not feeling stigma because of the types of people 
they acquaint themselves with, “I think it depends on the type of people that you date and I tend to 
date people that are educated so I could see where someone who was dating uneducated men or 
women, that they could feel more stigmatized” (Leslie). Another similarly articulated, “no [I do not feel 
stigma] but I guess on top of that, the part of society I interact with aligns very closely with what I 
believe and how I live my life” (Erica). Those that were aware of the high prevalence of HPV and/or 
associated with individuals who were more knowledgeable about HPV felt less HPV stigma. 
Three of these participants recognized the stigma attached to HPV even when they did not 
experience it themselves. One individual recalled a friends’ reaction to her own HPV diagnosis, “you 
would have thought she was the whore of Babylon. She thought she was a horrible person, ‘how could 
this happen, who could have given this to me? I have not had that much sex’” (McKenzie). Another 
participant explained how others with HPV often feel by saying, “I think that most people end up 
thinking they are punished or they are dirty or because that boy or that person or that bad decision... I 
think that everybody has that because sex has a terrible stigma attached to it” (Riley). This individual 
recalled how societal pressures on women translated into women with HPV feeling at blame, “I feel like 
since you can't test men, then it becomes the women's problem and the dirty slutty women, we are the 
ones carrying it around. It has that feel to it. And the women that I have known that are diagnosed have 
been devastated” (Riley). Another recalled men friends saying “she had HPV, she's gross” but equates 
this stigmatizing behavior to people being ignorant about HPV, “they are uneducated about it… I just tell 
 46 
them they are wrong and explain. It's just miseducation” (Leslie). These participants, even if 
experiencing no stigma personally, understood how many individuals with HPV could feel judged by 
others and internalize that judgement. 
 
3.6.1.2 Participants Who Felt Stigma  
Fourteen participants explicitly mentioned feeling stigma due to their HPV status. Ten of these 
participants felt judged by others. One did not tell her mother about her HPV “because there is a level of 
shame that comes with stuff like this that is not acceptable” (Ashley). Another worried what her family 
would think, saying: “I believe that they would [be judgmental]. My family on my mother's side …oh yes, 
they are very… a different breed. They would probably blame it on me…. ‘That's what you get’ type of 
thing” (Kaylee). Another told a friend for support and was shamed for it, “I told a friend of mine about 
what happened at the clinic [my diagnosis] and she told everybody that I had a venereal disease” 
(Ashley). One participant vocalized what she assumes others think about HPV, “most people who 
haven't done the research themselves, despite what I would have to say, would be very quick to just 
hear STD, and judgment, and all the stigma that comes along with that” (Amber). One individual worried 
about potential stigma from a friend, “I had a close friend at work and we were on a departmental team 
together and one of the girls was in and out a lot and she was having reproductive problems. So, my 
friend was like ‘she's a slut.... She has HPV’” (Summer). Another felt her status reflected poorly on her in 
the eyes of others, “if you say that you have HPV that is like saying I have had unprotected sex” 
(Whitney). She worried about being judged for her status and sexual behavior. 
Two of the participants who felt judged by others believed this was related to the form of cancer 
they had from HPV. One felt judged by the diagnosing doctor, recalling “it comes back [as] HPV and my 
doctor down here tells me I need to change my lifestyle…. He is supposed to be learned about these 
things and be accepting. Whether I was partaking in anal intercourse or not was not his call” (Theresa). 
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Another explained, “I was first diagnosed [with anal cancer] and I had to tell my boss and all of a sudden 
it was just like they did not want to hear about it. I think people are just very put off by cancer that is 
caused by something that could be sexually related.... Of course, nobody wants to say anal and when 
they do it is in a negative context” (Katherine). Both of these participants had HPV which led to anal 
cancer. They believed they were being judged for their status and cancer because of how they are 
acquired. 
Seven of these fourteen participants internalized the stigma and judged themselves. One 
individual explained, “she [mom] was kind of pissed at me for getting HPV and having to have this 
colposcopy11.... I remember not wanting to deal with that and maybe feeling a little ashamed and shitty 
like she was making me feel shitty” (Phoebe). Another stated, “I was really fascinated with how I was 
identifying with my body…the physical part of my body that nobody could see but me...and how much I 
internalized that. I felt dirty and I felt gross. I felt ugly and I did not feel sexually viable, but nobody knew 
that but me. Thinking about it…it grosses me out. It takes me back to that feeling of shame…really 
shameful. I did not do anything that shameful; it just kind of happened. But it made me feel shameful. I 
felt this internalized sense of dirty” (Emily). Another said, “there was a little bit of like...the dirty 
feeling.... I have a sexual.... No one wants to say that about themselves….[It] left a sour feeling in my 
stomach” (Summer). Another voiced similar feelings, stating, “it is just embarrassing and you know you 
feel dirty and feel that there is something wrong with me. After that [diagnosis], I feel ashamed” 
(Whitney). She continued, “I am kind of upset with myself. I know who exactly I got it from and I should 
have been more assertive about using.... You know, I judge myself. I should have been more assertive 
about using condoms…. I just feel like at my age, I should have known better” (Whitney). Another felt 
shame at her diagnosis, “after the diagnosis, I was like, that sucks. I really had pride about the fact that I 
                                                 
11 A colposcopy is often recommended after an abnormal pap result. During this procedure, a health care provider 
examines the cervix through a colposcope and, if need be, performs a biopsy of the cervix for laboratory testing 
(Johns Hopkins n.d.). 
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had never been diagnosed with an STD…. After this diagnosis, I thought, you can't say that anymore, you 
are like everybody else and you now have HPV which is considered an STI” (Colleen). A few of these 
participants blamed themselves for their diagnosis: “I guess you paid for that piece of ass” (Theresa), 
and “I think that I got genital warts, not because of the strain, but because I was treating my body very 
unhealthy” (Emily). All of these participants viewed themselves negatively at some point since their 
diagnosis because of their status, sexual behavior, or how others judged them. 
Three of these participants felt stigmatized when first diagnosed, but felt less so over time. One 
participant demonstrated that she was upset at diagnosis, but no longer internalizes that stigma, 
“growing up things I heard like STDs have a stigma … this connotation that she must sleep around or 
that he sleeps around or that I don't use protection or that I am not responsible.... I am dirty…damaged 
goods…. It was a rough moment… in that first day or two that I learned I had it.... That is why I was so 
upset because STDs have a very.... It is like…oh, I am that statistic now. I am part of that group.... So it 
was hard, but now it is no big deal to me now. I know more about it. I don't think that way anymore” 
(Ava). One participant explained, “[I felt stigma] just in the very beginning when my friend told people I 
had a venereal disease” (Ashley). Another stated, “it did feel like a little bit of a stigma. I had done a 
bunch of reading and it was like...it is ridiculously common and very easily transmitted and people often 
don't know if they have it. But it still, it did feel a little bit like...you know I had this disease now.... I don't 
think it was a very lasting kind of impact but I definitely was aware of it” (Jessie). These participants’ 
sense of self-blame and internalized stigma dissipated over time when they gained more knowledge 
about HPV. 
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3.6.2 Disclosure 
Twenty-two participants mentioned disclosing their HPV + status to at least one person in their life. 
These participants disclosed to friends, family members, sexual partners (see Article 3), and/or other 
people with HPV. Two of these individuals revealed their status to only one person in their life. 
Disclosure was often related to a feeling of stigma related to HPV, or a lack thereof. 
 
3.6.2.1 Stigma and Disclosure 
Twelve participants who felt stigma from their HPV status decided to disclose to individuals close to 
them for a variety of reasons. Two only told their sexual partner; one disclosed to only one person, a 
close friend; nine participants mentioned their HPV status to friends and/or family members. Some 
participants disclosed because it merely came up in conversation with their family or friends. Others 
tended to offer this information when giving advice to others. One explained, “whenever any of my 
friends mention their gynecologist doing any overt testing…I felt like they were treating me really 
aggressively and did a lot of stuff that didn't need to happen…. So recently I feel like I have been a lot 
more open about it to my friends” (Summer). Many of the participants disclosed to friends who had 
previously been diagnosed with HPV or who were more knowledgeable about the STI. One individual 
stated, “[I told] one of the girls I worked with because she had gone through it. I just asked her about it 
one day. She is my older friend. I just asked if she had ever had the same issue and she had. She was like 
yeah it is super uncomfortable but lots of women have had to deal with it [HPV and colposcopy]. She 
was the only person I really talked to about it because it was just this thing I had to do” (Ashley). One 
recalled that she mentioned having it after her friend revealed her own status, however, she refrained 
from disclosing all aspects of her diagnosis, “the only thing I don't talk about is the genital warts” 
(Emily). Others told friends who may have been more knowledgeable about HPV. One recalled, “I talked 
to my roommate who is a nurse because I had told her before I got diagnosed. I was like there is this 
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thing that I got - what do I do?” (Ava). These participants decided to tell their status to others in order to 
gain knowledge about their own diagnosis or to inform others about HPV.  
The participant who disclosed to only one friend recalled telling her right after diagnosis, “I'm 
like, ‘guess what just happened? I got a call about my pap smear.’ I called her like, ‘do you believe this?’ I 
made a special call with that in mind” (Janelle). Although this friend was supportive, she knew very little 
about HPV; “she did not know anything more than I did so she wanted to know what I found out about 
HPV” (Janelle). Most participants who disclosed to their friends felt supported. Friends often pointed out 
that HPV was “really common and they were sure I would be fine,” (Jessie) and, “it's no big deal, this 
happens all the time” (Summer).  
 
 
3.6.2.2 Stigma and Non- Disclosure 
One individual made the conscious decision to tell no one. This participant stated that her 
motivation for non-disclosure was related to the judgment she would receive due to people’s lack of 
HPV knowledge: “I just feel like it would be awkward you know telling someone that you have an STI. 
Especially the people that I talk to that are not really educated about it - I don't want an ignorant 
response” (Kendra). This individual also felt that friends would pass judgment, therefore she did not 
disclose her status to them: “they are virgins so our conversations about sex are very limited. It would 
be awkward to tell them because they just want to dis it” (Kendra). This participants assumed that 
individuals in her life lacked the necessary sexual experience and HPV knowledge to understand her 
status. 
Fourteen of the participants who felt stigma at some point in their life related to their HPV 
status refrained from disclosing their status to some individuals close to them. Eight did not tell their 
status to their most recent sexual partners, and one did not mention it to any of their sexual partners. 
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(Disclosure to sexual partners is the topic of another article.) Six participants chose to not disclose their 
status to others close to them. 
A few participants withheld their status from specific individuals in their life while telling others. 
One withheld this information from her mother’s side of the family, also due to fear of stigma, stating, 
“it’s not like they aren't going to be judgmental or anything. I just wanted to keep it to myself” (Kaylee). 
However, this participant also did not tell the rest of her family about her status because she felt 
disclosure was not important due to HPV’s prevalence: “I haven't mentioned it. I don't know.... It seems 
like it has been normalized. It is not so much of a big deal to me for me to tell anyone else because there 
are lots of people that are going through it too” (Kaylee). Another individual voiced similar motivations 
for non-disclosure to most friends and family stating, “I guess if it had been something I was more 
worried about especially with my medical health, I would have talked to my parents about it” (Jessie). 
These participants felt they had nothing to gain from disclosure because it was not a cause for concern. 
Another withheld her status from friends, not due to stigma, but due to there being no benefit in 
disclosing, “because it is none of their [friends’] business. They can't help me. There is absolutely 
nothing they can do to help me” (Janelle). She felt that telling others about her status would not help 
her handle the aftermath of her diagnosis.  
   
 
3.6.2.3 No Stigma and Disclosure 
Nine participants who felt little to no stigma related to their HPV status disclosed their status. Many 
of these participants discussed HPV with friends who had been previously diagnosed or had undergone 
HPV-related procedures. One felt relieved after discussing HPV with friends who had it, saying, “that 
they essentially had the same diagnosis that I did and like a year later they didn't have it anymore and it 
didn't affect their sex life or their life in general” (Leslie). This participant reached out to friends she 
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knew who had HPV to ask about their experiences, “I was having to get those procedures done. I was 
asking if anyone had it before and one of them had and we talked about it” (Leslie). Another recalled, 
“One of my good friends was diagnosed with the genital warts type. So, I talked to her about it” (Carla). 
These participants felt supported by their friends and gained valuable knowledge about HPV, both of 
which may have led to less feelings of stigmatization. 
Three participants were very open about having HPV. One noted how she tells most people, but 
educates them while doing so, “I am very open with my friends... if I am around a conversation where 
people are talking about STDs... I will disclose … to educate people” (McKenzie). Another mentioned, “I 
would tell anybody. If it was a topic of conversation and relevant, I would happily speak about it” (Riley). 
These participants were very candid about their status and disclosed to most people in their lives. 
Others felt open about their status, yet did not tell everyone in their life. One participant 
revealed her status to her partner and family, yet did not reveal it to most friends. This was not a 
purposeful non-disclosure, as she states, “we are a fairly open group so I don't think that it was 
something that I tried to hide. If it had come up in conversation I don't think I would have been worried 
to disclose.... Just to the best of my recollection I don't think it came up” (Leah). Many participants said 
that they would disclose if it came up in conversation with friends or family. One individual, who was 
diagnosed a year prior to the interview, mentioned how the passage of time since diagnosis has made 
disclosure easier: “I think the farther away it has gotten from the diagnosis, it is not something I feel like 
I need to hide if it ever came up in a conversation” (Erica). Although this participant felt little to no HPV 
stigma and openly disclosed to friends, she is now more candid about her status with others in her life if 
it is relevant to the conversation.  
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Two participants disclosed their status to a few family members and friends only in the context 
of HPV-related treatment and lab results (LEEP12, abnormal pap smear, colposcopy) while rarely drawing 
a connection to HPV. One participant decided to not disclose her HPV to most of the people in her life, 
but discussed treatments with friends and family members recalling, “when I was going to be out for a 
few days [for LEEP] and that was it…I think I probably glossed over the fact that you need LEEP if you 
have HPV - the connection” (Candace). She did, however, draw the connection, and thus disclosed her 
status, to close friends, “I think the only time I disclosed was when I was about to have the LEEP and 
people wanted to know why…I think I said it was because of HPV” (Candace). Another participant 
disclosed her HPV to her sexual partner but only discussed treatments with family while withholding her 
HPV status from them, “I talked to my parents and sister about the treatments. No one has ever 
mentioned HPV. I haven't mentioned it to them. I don't want to have that conversation with my 
mother” (Andrea). She assumed her parents and sister did not understand that the treatments were 
associated with HPV because they did not draw the connection on their own and discuss it with her. 
 
3.7 LIMITATIONS 
Past qualitative research on HPV has relied on non-diverse samples of primarily white, college-
educated women (see: Kosenko et al. 2012, Nack 2008). Although I sought to reveal the stories of a 
diverse sample in terms of ethnicity, race, and educational attainment level, my sample was more 
homogeneous than initially intended. My sample included cis-gender and gender non-conforming 
women from different racial and ethnic groups ranging in age. However, I was unable to include 
participants of varying levels of educational attainment. This may have been a result of my sampling 
method. However, I also believe it is due to the fact that women with lower socioeconomic status and 
                                                 
12 With LEEP, an electric current heated wire loop removes abnormal cells and tissues in the cervix and vagina. The 
tissue is then sent to a lab for testing. LEEP is often performed in order to detect cancer of the cervix or vagina 
(Johns Hopkins n.d.). 
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less education are less likely to have regular gynecological appointments and routine Pap tests, 
compared to their more educated peers (Behbakht et al. 2004; Katz and Hofer 1994). Without regular 
visits to the gynecologist and routine Pap tests, women are much less likely to know they are HPV 
positive. Therefore, individuals who saw my flyers may have thought they did not qualify because they 
did not know their positive status.  
Despite this limitation, my research adds knowledge to the field because of the rich detail my 
participants provided during their interviews. Many past researchers used surveys to analyze 
knowledge, awareness, and attitudes regarding HPV, but qualitative researchers have found that semi-
structured interviews allow participants to explain personal experiences related to this diagnosis (see: 
Gerend and Magloire 2008; Lee and Craft 2002). My work differs from existing studies where 
researchers ask undiagnosed women how they would feel if they were diagnosed with HPV (see, e.g., 
Waller et al. 2007a). My interviews of HPV+ participants fostered detailed discussion of actual lived 
experiences related to HPV diagnosis, disclosure, and stigma. 
 
3.8 DISCUSSION 
According to past research, some HPV + individuals do not feel stigma associated with their 
diagnosis and instead view it as an inevitable consequence of being sexually active (McCaffery 2006). 
While nine of the participants in this study felt little to no stigma associated with their status, fourteen 
did feel stigma associated with having HPV. 
Individuals’ embarrassment and shame surrounding diagnosis often stems from the 
connotations of promiscuity associated with STIs (McCaffery et al. 2006). My findings support this past 
research, with many of my participants voicing worry about being judged for having a sexually 
transmitted infection. They thought others would associate their diagnosis with having unprotected sex 
and sleeping around. Individuals with STIs may face increased prejudice because they potentially caused 
 55 
their own stigma (Breitkopf 2004; Nack 2008). Attribution theorists posit that those who are seen as 
contributors to their own illness are often more harshly judged by others (Lebel and Devins 2008; 
Weiner, Perry and Magnusson 1988). It is socially acceptable to blame individuals for contracting 
infectious illnesses (Breitkopf 2004; Nack 2008). Research indicates that blame is more often attributed 
to women with cervical cancer than to individuals with cancers unrelated to lifestyle choices, such as 
leukemia, breast, or bowel cancer (Marlow et al. 2010, 1802). While many of my participants worried 
about judgment from friends or family due to their status being linked to sexual behaviors, only one felt 
this judgment from their diagnosing doctor. This participant felt that her doctor was blaming her for 
having HPV because of assumed sexual behavior. 
Women with STIs often internalize this stigma (East et al. 2012). In fact, the most commonly 
reported type of stigma among individuals with HPV is negative self-image stigma (Barnack-Tavlaris et al. 
2016). Women with HPV often refer to themselves as “unclean, “dirty”, “cheap”, “gross” (East et al. 
2012, 17; McCaffery et al. 2006; Nack 2008, 66). Some of my participants echoed these sentiments and 
mentioned feeling “ashamed”, “dirty”, “gross”, “ugly”, “damaged”, and “no longer sexually viable”. 
Women sometimes stated that their diagnosis signified them paying for past behaviors (Daley et al. 
2008). A few of my participants recalled feeling disappointed in themselves for not using condoms or 
having safer sex. Others recalled feeling that their diagnosis was retribution for having sex with a 
particular person or for treating their body poorly. Researchers have found this type of self-blame is 
more common among individuals with STIs, such as HIV, compared to unavoidable illnesses, such as 
some forms of cancer (Fife and Wright 2000).  
When an individual’s “differentness is not immediately apparent, and is not known 
beforehand,” she has a discreditable stigma, according to Goffman (1963, p. 42). My participants’ HPV 
status was not known to others unless disclosed, making them discreditable. Discreditable individuals 
engage in strategies of stigma management to control the information that others know about their 
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discreditable attribute (Goffman 1963). Many individuals with HPV feel personalized stigma, where they 
worry that others will not understand their diagnosis and reject them (Barnack-Tavlaris et al. 2016). 
According to previous research, women with HPV feel anxiety about disclosing their status to family and 
friends (East et al. 2012; Kosenko et al. 2012). Women with HPV often chose not to disclose their stigma 
to others because they fear rejection from their friends, family, and sexual partners (Barnack-Tavlaris et 
al. 2016; Nack 2008:91). Therefore, some individuals do not disclose their positive status in order to 
avoid making a stressful situation more anxiety provoking (McCaffery et al. 2006). Over half of my 
participants withheld this information from many individuals close to them due to fear of rejection and 
judgment. One individual had not disclosed to anyone for the same reasons.  
 Individuals with a discreditable stigma may choose, however, to disclose their 
discreditable attribute to others as a form of “stigma management” (Breitkopf 2004; Goffman 
1963:100). Many women with HPV eventually disclose their stigma because they feel increasing guilt 
about concealing it from friends and family (Nack 2008:91). Selective disclosure, another strategy for 
managing stigma, is when an individual conceals their stigma to most and discloses it to a few people, 
usually their intimates, family members, and doctors (Goffman, 1963). The majority of my participants 
decided to disclose their status to at least one person in their life, their sexual partner(s), close friend(s), 
or family member(s), but very few disclosed to everyone.  
As a form of stigma management, individuals may pose as having a similar, yet less stigmatizing 
condition in order to avoid judgement (Goffman 1963). Past research demonstrates that some 
individuals chose to disclose their abnormal pap smear results rather than their HPV status (McCaffery 
et al. 2006). A few of my participants mentioned their abnormal results or their HPV-related procedures 
rather than disclosing their status as a way of avoiding full disclosure. By mentioning their lab results, 
LEEP, or colposcopy these individuals made their friends and family aware that they were undergoing 
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some type of cervical condition, but they did not disclose that this was related to a sexually transmitted 
infection.  
According to Goffman, close relationships cause a discreditable person to disclose their secret or 
feel guilty for not doing so (1963). Many women disclose in order to gain the support of loved ones (Lee 
and Craft 2002). All but one of my participants disclosed to close friends, family, or partners who were 
supportive. One individual faced a single judgmental friend, but later found support in others. Seven 
participants disclosed to friends who had previously been diagnosed or who had undergone an HPV-
related procedure. These participants found support and reassurance by disclosing their status. In-depth 
HPV research reveals that after diagnosis, women face the harsh reality that many of their close friends 
and family now see them as diseased (Nack 2008). Fortunately, this was not the case for my 22 
participants who felt loved and supported once disclosing their status to select friends and/or family.  
Another stigma management strategy for those with discreditable stigmas is self- disclosure 
(Goffman, 1963, p. 100). An individual can self-disclose by openly admitting to having the stigma 
(Goffman, 1963, p. 101). Many of my participants disclosed their status although they felt no stigma 
associated with it. Many recalled that they disclosed because it merely came up in conversation. Others 
told their HPV experience to individuals who had since been diagnosed as a way of offering advice and 
support. Seven participants stated that their disclosure to others was a means for them to help 
educated people about HPV. Goffman asserted that if an individual “accepts himself and respects 
himself he will feel no need to conceal his failing” (Goffman, 1963, p. 101), three of my participants had 
reached this point of self-acceptance and shared their HPV experience with most everyone in their lives.  
Individuals with HPV often feel embarrassed about their diagnosis (Daley et al. 2008; Nack 
2008). This embarrassment can lead to self-blame and non-disclosure of status. Although thirteen of my 
participants felt HPV stigma at some point since diagnosis, almost all of them (12 of 13) told someone in 
their life about their status. This disclosure is often beneficial to those with HPV. It can be cathartic and 
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allow them to seek sympathy and acceptance from close friends and family members (Nack 2008: 98). 
My participants gained support and knowledge from their disclosure. Both of which were valuable 
resources while trying to navigate what being HPV positive meant to them. 
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4 “They Probably Already Had It Anyway”: Status Disclosure and Sexual Behavior 
4.1 ABSTRACT 
Human Papillomavirus (HPV) is the most prevalent sexually transmitted infection in the United 
States, however, many Americans do not use preventive methods to protect themselves and others 
from transmission. This study uses in-person, semi-structured interviews to examine status disclosure 
and sexual behavior among those with HPV. It also analyzes how HPV transmission knowledge impacts 
motivations and intentions to participate in prevention behaviors. The study found that post-diagnosis 
many individuals were ill-informed about HPV transmission and how HPV impacts men. This study also 
found that few individuals with HPV disclosed their status to all at-risk sex partners or used barrier 
methods consistently during sex. These findings suggest that more work is needed to facilitate effective 
HPV education which includes status disclosure and use of all barrier methods. 
 
4.2 INTRODUCTION  
Human Papillomavirus (HPV) is the most prevalent sexually transmitted infection in the U.S. 
(CDC 2017a). Nearly 79 million Americans are infected with HPV, with 14 million becoming newly 
infected annually (CDC 2017a). Over 40 types of HPV are transmitted through vaginal, anal, and oral sex, 
or intimate skin-to-skin contact (CDC 2013; Moscicki 2005). Men are not currently tested for HPV and 
screening tests are not available for HPV-related cancers or genital warts in men (CDC 2017b). The vast 
majority of women diagnosed with HPV have strains that present low-risk for cancer (CDC 2013). At 
least two of these low-risk strains are associated with genital warts, which are also transmitted through 
sexual contact, highly infectious, and very common (WHO 2016).   
HPV is the primary cause of cervical cancer in the U.S., with over 90% of cases caused by HPV 
(CDC 2017c; Nan 2012). There are over 100 subtypes of HPV; however, only a few are associated with 
cervical cancer (CDC 2013; Polzer and Knabe 2012). These high-risk types of HPV are also associated with 
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other cancers. Anal cancer is strongly associated with high-risk HPV, although its occurrence is rare 
(ASHA 2018). Over 80% of anal cancers in the United States are caused by high-risk HPV (CDC 2017c). 
Men and women, especially those with a history of severe cervical dysplasia, can be affected by HPV-
related anal cancer (ASHA 2018). Head and neck cancers are also rare, but 70% of cases are associated 
with high-risk HPV transmitted through oral sex (CDC 2017c; ASHA 2018). Penile cancer is extremely 
rare, but has been linked to high-risk HPV in over 60% of cases (CDC 2017c; ASHA 2018). HPV is also 
associated the rare vaginal and vulvar cancers, making up over 70% of those cases (CDC 2017c; ASHA 
2018). 
 
4.2.1 HPV Knowledge 
 
Many Americans are unaware of HPV’s prevalence and risk of transmission (Blake et al. 2015; 
Gerend and Magloire 2008; Sandfort and Pleasant 2009; Ratanasiripog et al. 2013). This knowledge 
varies based on level of health literacy, education, age, and race (Blake et al. 2015; Kutner 2006). 
However, even college educated individuals who are aware of HPV’s link to cervical cancer, tend to be 
less knowledgeable about its prevalence and often do not perceive themselves at risk (Gerend and 
Magloire 2008; Sandfort and Pleasant 2009; Ratanasiripong et al. 2013; Blake et al. 2015). These 
individuals are also often unaware of HPV-related health threats to men and the risk of developing 
genital or cervical warts (Sandfort and Pleasant 2009).  
Prior to HPV+ diagnosis, many women report little concern about their health at the time of 
their first abnormal Pap (Sharpe et al. 2006). Even women recently diagnosed with HPV lack information 
about the infection (Perrin et al. 2006; Sharpe et al. 2006). They are confused about the symptoms, 
treatment options, and recommended lifestyle changes (Perrin et al. 2006). Research indicates that 
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women with HPV often lack knowledge about the sexual transmission and high prevalence of HPV 
(Sharpe et al. 2006). 
The HPV vaccine protects against persistent infection of HPV subtypes associated with most 
cancers and genital and cervical warts (Rothman 2009; Brelsford 2011). In June of 2006 the HPV vaccine 
was approved and recommended for girls aged 11-26 (allowing 9 and 10-year-old girls to be eligible for 
the vaccine) (Braun and Phoun 2010; CDC 2011; Connell and Hunt 2010; Shefer et al. 2008; Wailoo et al. 
2010). Although young girls (11 and 12-year-olds) are the targeted demographic for vaccination, 
routinely the vaccination requires surrogate decision making, whereby parents decide if their child gets 
vaccinated (Chapman 2010; Connell and Hunt 2010). Research demonstrates that parents of girls often 
intend to vaccinate them against HPV before the age of 13 (Constantine and Jerman 2007). Vaccine 
uptake among male adolescents is lower than females because most parents report a lack of awareness 
of the health consequences for men and the possibility of administering the vaccine to boys (Reiter et al. 
2011; Voss and Wofford 2016). In general, parents of girls and boys view the vaccine as safe and 
effective in preventing cancer (Alexander et al. 2012; Brewer and Fazekas 2007; Rosenthal et al. 2008).  
HPV vaccination intention is lower among older adolescents and college age women, compared 
to younger girls. The most commonly cited barriers to vaccine intent among college age women were: 
vaccine safety concerns, side effects, insurance issues, cost, and low perceived risk (Patel et al. 2012). 
Past research demonstrates that younger (18 to 21-year-olds), white, insured women were more likely 
to receive a doctor’s recommendation for the vaccine compared to older (22 to 26-year-olds), 
uninsured, minority women (Gerend et al. 2015). Not surprisingly, the same demographic group is more 
likely to receive the HPV vaccine: white, insured, 18 to 20-year-old women (Laz et al. 2013). The most 
commonly cited barriers to vaccine intent and uptake among 18 to 26-year-old women were: vaccine 
safety concerns, side effects, insurance issues, cost, low perceived risk, and the belief they were too old 
to receive the vaccine (Laz et al. 2013; Patel et al. 2012). According to the CDC, the vaccine is not 
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recommended for women over the age of 26 because it offered limited protection against HPV-related 
diseases in clinical trials due to the fact that most women had already been exposed to one or more HPV 
strains in their late teens or early twenties (CDC 2017d). However, research suggests that the vaccine 
may be beneficial to older women, even those who are HPV positive. In fact, previously infected 
individuals may benefit from vaccination by increasing antibodies and thus helping individuals clear HPV 
more quickly and prevent re-infection (Muderspach et al. 2000; Scherer et al. 2016). 
 
 
 
4.2.2 Non-Disclosure  
 
A key element of safer sex is understanding one’s risk of acquiring an STI from your one’s 
partner/s. To understand this, partners must be honest about their own sexual health and disclose any 
positive STI statuses (Emmers-Sommer et al. 2010; Luchetti 2009). Past research indicates a large 
portion of college students are unaware that disclosure is a component of safer sex practices (Luchetti 
2009). However, most college students believe it is appropriate to disclose a positive STI status to one’s 
casual or serious partner prior to having sex for the first time with this partner (Emmers-Sommer et al. 
2010). However, these individuals cited many barriers to disclosure, including embarrassment and fear 
of rejection by partners (Emmers-Sommer et al. 2010). Research also demonstrates that some 
individuals knowingly misrepresent their STI status to their partners (Luchetti 2009). 
Many women with HPV believe that their diagnosis will affect their sexual relationships, and 
thus feel anxiety about disclosing their status to sexual partners (East et al. 2012; McCaffery et al. 2006). 
Some women with HPV do not disclose their status to sexual partners because of shame and lack of 
knowledge (McCaffery et al. 2006). Many women delay disclosure until just before having sex with their 
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partner (Nack 2008). Individuals may decide to continue to have sexual relationships without disclosing 
their STI status with their partner. Some women do not disclose their status until after having sex with 
their partner, for fear of rejection (Nack 2008).   
 
4.2.3 Inconsistent Condom Use 
 
Researchers have long posited that consistent condom use is related to condom use self-
efficacy, or an individual’s belief that they have the capabilities to control sexual situations (Artistico et 
al. 2014; Bandura 1990; Bryan et al. 1997). Gendered condom use self-efficacy findings are mixed. 
According to some research, women report lower condom use self-efficacy scores compared to men 
(Farmer and Meston 2006; Roberts and Kennedy 2006; Wildsmith et al. 2010). This is because, for 
women, condom use self-efficacy involves agency over sexual communication and negotiation with 
partners (Artistico et al. 2014; French and Holland 2011). Other researchers posit that women have 
greater condom use self-efficacy than men, are more likely to engage in safer sex communication, and 
have a more active role in condom negotiation while men have a more reactive role (Allen et al. 2002; 
Carter et al. 1999). Women claim that they feel capable of convincing their partner to use a condom 
even if the partner does not want to and men are more likely to report being convinced to use a condom 
if their partner wants to (Carter et al. 1999). However, women who perceive themselves to have less 
decision-making power in their relationship are less likely to report consistent condom use (Pulerwitz et 
al. 2002). Women’s intent to use condoms is also often derailed by their partner’s negative attitude 
towards condoms (Farmer and Meston 2006; Roberts and Kennedy 2006). Men claim that they can 
convince their female partners to have condomless sex even if she wanted to use a condom (Carter et 
al. 1999). Women often report condom non-use because they believe condoms will decrease their 
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partners pleasure during sex and they do not perceive themselves at risk for STIs (Roberts and Kennedy 
2006).  
Consistent condom use is also associated with perceived risk of STIs and intent to use condoms 
(Bryan et al. 1997). However, most individuals’ perceived risk is lower than their actual risk for acquiring 
an STI (Farmer and Meston 2006; Roberts and Kennedy 2006; Wildsmith et al. 2010). Individuals with 
past STI diagnosis also do not perceive themselves at risk (DiClemente et al. 2002). They are not any 
more likely to report condom use and are thus at risk for subsequent infection of STIs (DiClemente et al. 
2002).  
According to nationally representative research, only 23% of young adults aged 18 to 26 in 
dating relationships used dual methods (condoms and hormonal birth control) and 26% used only 
condoms (Manlove et al. 2011). Condom use decreased and hormonal contraception use increased in 
these relationships as the duration and level of intimacy increased (Manlove et al. 2011). Individuals in 
serious relationships are less likely to use condoms compared to single individuals (Emmers-Sommer et 
al. 2010; Roberts and Kennedy 2006). Individuals in long-term relationships no longer view their partner 
as an STI risk and as trust and a sense of security increases in a relationship, condoms are no longer 
viewed as a necessary precaution (Emmers-Sommer et al. 2010; Manlove et al. 2011; Roberts and 
Kennedy 2006).  
Findings on the effectiveness of condoms in HPV transmission prevention are mixed. Some 
studies show that condom use is related to a decreased risk for positive HPV status and development of 
dysplasia (Manhart and Koutsky 2002; Winer et al. 2006). Research demonstrates that male-to-female 
genital HPV transmission, specifically, is reduced by condom use (Winer et al. 2006). Other research 
indicates an elevated risk for positive HPV status and development of dysplasia among women who use 
condoms (Kjaer et al. 1997; Manhart and Koutsky 2002). This increased risk may be related to timing of 
condom use (used after HPV was acquired) or to ineffectiveness of condoms on initial HPV infection 
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(Manhart and Koutsky 2002). More recent research, however, posits that women whose partners use 
condoms over 50 percent of the time are at reduced risk for acquiring a new HPV infection, both low-
risk and high-risk types (Winer et al. 2006). Studies also show that condoms and dental dams provide 
protection against cervical cancer in women, HPV-related genital warts in both men and women, and 
oral HPV infection in men (Edelstein et al. 2012; Manhart and Koutsky 2002).  
 
 
 
4.3 THEORY 
4.3.1 Information, Motivation, Behavior Model 
The information, motivation, behavior (IMB) model is an appropriate theoretical framework 
through which to investigate disclosure and sexual practice among the HPV positive. This model was 
established to predict HIV prevention based on the concept that information, motivation, and 
behavioral skills determine preventive behavior (Bahrami and Zarani 2015). The key elements of this 
model applied to primary and secondary STI prevention include: STI knowledge related to transmission 
and prevention techniques; motivation to change risky behavior and practice preventive behavior 
related to one’s beliefs and attitudes; perception of personal risk of contracting and transmitting the STI; 
perceived self-efficacy to perform STI prevention behaviors, such as condom and dental dam use, 
condom negotiation, and disclosure of status (Bahrami and Zarani 2015; St. Lawrence and Fortenberry 
2007).       
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4.4 CURRENT STUDY 
Disclosure and sexual behavior related to HPV diagnosis is a relatively new direction in research. 
Most researchers have focused on the impact of condom use on HPV transmission (see: Manhart and 
Koutsky 2002; Winer et al. 2006) or disclosure among individuals with a multitude of STIs including HPV, 
genital herpes, and chlamydia (see East et al. 2012, Nack 2000). Through my research, I sought to 
discover how an HPV + status influenced my participants’ sex lives, feelings about disclosure, and 
reasons for not disclosing to sexual partners. 
 
4.5 METHODS 
Due to the fact that individuals with STIs qualify as a hard-to-reach population and recruitment 
can be difficult (Dixon-Woods et al. 2001; Nack 2008), I employed purposive, facility-based sampling and 
snowball sampling. I utilized key locations to find study participants (Magnani et al. 2005), such the 
health clinic at a large public university in the Southeastern United States and multiple privately-
operated gynecological clinics around a large metropolitan area in the Southeastern United States. 
Commonly cited barriers to STI screenings include cost, privacy, language barriers, and perceived 
discrimination at the clinical site (Tilson et al. 2004). Therefore, I chose to include clinics that offer free 
or low-cost STI screening services to English and non-English speakers and that abide by anti-
discrimination laws specific to patient admission and treatment. I also posted flyers around two major 
universities, high-traffic pedestrian areas, and throughout diverse neighborhoods. Additionally, I gained 
entry into online support groups for individuals with HPV13 to recruit group members for my study. In 
order to allow for fully informed consent on the part of my subjects, I included accurate and 
straightforward information about my research and its purposes. 
                                                 
13 http://www.dailystrength.org/c/HPV/support-group; http://hpvsupport.com/phpBB3/; 
http://www.mdjunction.com/hpv; http://hpv.supportgroups.com/; http://www.hpvhope.com/support.html;  
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I recruited my participants via advertisements (flyers) displayed and distributed at the recruitment 
facilities. This discreet recruitment method is commonly used among STI researchers (see: Kosenko et al. 
2012; East et al. 2012) so that interested parties can contact the researcher anonymously with any 
questions. Multiple versions of the flyer were distributed with various photos of young girls and women 
from different racial and ethnic groups on them in order to appeal to a diverse group of potential 
participants. Each flyer contained tear-off tabs so that interested parties could easily obtain my contact 
information. Additionally, each flyer included a Quick Response code. Quick Response codes are an 
increasingly popular advertisement tool that can be scanned and read by smartphones (Shin, Jung, and 
Chang 2012). The flyers contained a unique Quick Response code that linked smartphone users to my 
online eligibility form. This eligibility form required users to enter their age and HPV status and then, if 
eligible and interested in participating, their contact information was automatically sent to me.  
 
4.5.1 Sample Demographics 
I gave all of my participants pseudonyms to protect their identity. My participants included 23 
women of various ages14. Six were in their 20s, eleven in their 30s, three in their 40s, two in their 50s, 
and one over 60 years old. Sixteen of the 23 participants grew up in a two-parent family; three had a 
single parent; three had divorced parents and stepparents in the home; and one had divorced parents 
that never remarried. Twelve of my participants grew up in the Southeastern United States; six grew up 
in the Northeast; three grew up in the Midwest; and two grew up outside of the United States. Fifteen 
of the participants resided in the Southeastern U.S. at the time of their interviews with three living in 
the Northeast; one in the Southwest; two in the West; and two outside of the United States. My sample 
was a highly educated group, with 10 of my participants having obtained a graduate degree, four in 
                                                 
14 My sample originally included 25 individuals, but after the interview, I determined that two no longer qualified 
to be included, due to their type of HPV. Both of those original participants had HPV that manifested as skin warts 
on the hands and feet – a condition that is not considered a sexually transmitted infection and is not related to 
reproductive issues or cancers. 
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graduate school at the time of interview, six obtaining a terminal Bachelor’s degree, one currently in 
undergraduate school at the time of interview, one having had some college education, and one having 
a GED as highest level of education. Regarding occupation, eight worked in health and medicine, four in 
education, three in law, three in the arts, one in business administration, one in marketing, one in 
plumbing/engineering, and two as current students. The majority of my participants were white (n=17, 
73.9%), five (21.7%) were black, and one (4.35%) was multiracial. Ten of my participants were single at 
the time of interview, 8 were in a committed relationship, and 5 were legally married. In terms of 
gender identity, 22 of my participants identified as women and one identified as gender queer. In terms 
of sexual orientation, 18 classified themselves as heterosexual, one as lesbian, and four as bisexual.  
 
 
 
4.5.2 Interview Method 
 
 Although many past researchers have used surveys to analyze knowledge, awareness, 
and attitudes regarding HPV and the vaccine, other researchers find that semi-structured interviews 
allow participants to explain their personal experiences of dealing with STI diagnosis and what this 
diagnosis meant to them (see: Gerend and Magloire 2008; Lee and Craft 2002). Interviews of HPV+ 
participants, compared to survey research, are more likely to foster discussion of actual lived 
experiences related to living with HPV and disclosure to others, and stigma. 
 As a feminist interviewer, I was cognizant of my role as a researcher and my potential 
source of authority during the interview process (Hesse-Biber 2007). In order to diminish the 
hierarchical relationship between researcher and participants, after each interview, I shared relevant 
aspects of my own biography (Hesse-Biber 2007) and experience with HPV. I strove to be reflexive and 
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to consider how my biography, values, and attitudes influenced the research process (DeVault and Gross 
2012; Hesse-Biber 2007). As a woman with HPV, throughout the interview and analysis stages, I 
reflected on how my attitudes regarding the disease impacted my choice of interview questions and my 
interpretation of participants’ responses (DeVault and Gross 2012). For example, I was motivated to ask 
about disclosure to sexual partners because of my own decision-making about disclosure. My personal 
experience also helped me understand the participants’ motivations to disclose or withhold this 
information from sexual partners.  
Interview topics included: what participants knew about HPV post-diagnosis, to whom they 
disclosed their status, reasons for their disclosure and non-disclosure of status, and how their diagnosis 
impacted their sex life, if at all. 
 
4.5.3 Analysis 
I conducted, recorded, and transcribed all of the interviews. I imported all transcribed materials 
into NVivo and analyzed them using a grounded theory approach. I chose this analytic method because 
it is well suited for understanding social processes not yet commonly researched (Hutchison et al. 2010). 
And, as noted above, there have been very few qualitative studies on the lived experiences of 
individuals with HPV. From my transcription and pre-analysis coding, I identified a few themes that I 
wanted to further investigate related to consequences of HPV: “feelings about HPV,” “impact on sex 
life” and “disclosure to sexual partners.” I analyzed the transcripts using the triadic coding scheme of 
open, axial, and selective coding (LaRossa 2005). During open coding, I identified major themes related 
to consequences of HPV, impact on sex life and disclosure to sexual partners, and deciphered what each 
concept represented (Lofland et al. 2005; LaRossa 2005). In the context of their diagnosis, each 
participant mentioned how their diagnosis impacted their sexual relationships. I then reviewed the 
concepts for similarities and variations, assigned them to categories, and identified the most salient 
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categories (Corbin and Strauss 1990). I analyzed participant feelings and knowledge post diagnosis, 
whether or not participants disclosed their status to past and present partners, why they did or did not 
disclose, and how their diagnosis impacted their sex life.  
In the axial coding stage, I analyzed the categories to determine how and why they differed 
among the participants, by focusing on the context, strategies, and consequences associated with each 
category (Corbin and Strauss 1990; LaRossa 2005). I analyzed relationships between participants’ 
experience with the diagnosis, disclosure and sexual behavior. Finally, I moved on to the selective coding 
stage of my analysis, where I decided which categories were most representative of the central 
argument of my analysis (Corbin and Strauss 1990; LaRossa 2005). I found the relationships of (1) 
feelings and knowledge about HPV impacting sexual behavior and (2) feelings and knowledge about HPV 
impacting disclosure of status to sexual partners to be most informative in this study. 
 
4.6 FINDINGS 
4.6.1 HPV & Prevention Knowledge  
My participants had a variety of HPV types and stages of cervical dysplasia. Cervical dysplasia 
indicates abnormal cells on the cervix surface that may clear or develop into cancer depending on the 
severity of the dysplasia (Mayo 2017). Six did not know whether their type was high-risk or low-risk or 
what level of cervical dysplasia they had at the time of interview. Without this knowledge, these 
individuals were unaware of the potential risk they may have been causing their partners or their 
partners’ future partners. Three individuals had an HPV strain that led to the development of anogenital 
warts at their vaginal opening, inside their vagina, or inside their cervix. Anogenital warts are easily 
transmitted through sexual contact and thus, potentially consequential for sexual partners. Five 
participants stated that they had low-risk HPV, which is asymptomatic, does not lead to cancer, and 
usually clears from the body within a few years. This type of HPV poses little risk to one’s sexual 
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partners. One participant knew she had a high-risk strain of HPV that was more commonly linked to 
cervical cancer. Two individuals had mild dysplasia (level 2) and four participants knew they had 
moderate to severe dysplasia (level 3 or 4). The higher the level of dysplasia, the more likely it will lead 
to cancer if left untreated. Two of my participants had developed anal cancer by the time of our 
interview. This type of cancer is rare in women, but can develop from severe cervical dysplasia. Although 
most high-risk strains of HPV that lead to higher levels of dysplasia do not lead to cancer in males, male 
partners can acquire a high-risk strain and then transmit it to future female sex partners or re-infect 
their current partner once it has cleared from her body.  
In another article, I analyzed my participants’ HPV knowledge pre and post-diagnosis. Eight 
participants remained unaware of the high prevalence of HPV after their diagnosis. Nineteen of the 
participants did not know that HPV could be contracted through skin-to-skin contact and did not require 
penile-vaginal or penile-anal penetration. Only two individuals explicitly stated that condoms would not 
completely protect a person from contracting HPV. They stated: “there is no 100% and I think it is a false 
sense of security people do get from using condoms” (Riley), and “people probably don't know that HPV 
is transmitted by skin-to-skin contact, and you can use condoms but it is not just about covering an 
orifice. You would have to have sex with a rubber suit on” (Colleen). Only two more participants knew 
that HPV could be transmitted from skin-to-skin contact and did not require penetrative sex. Many of 
my participants lacked this knowledge of HPV transmission and thus, did not use recommended 
protection, such as condoms and dental dams.  
Despite most participants not having a complete understanding of how HPV is transmitted, nine 
of my 23 participants voiced concern about transmitting HPV. Seven participants worried about infecting 
their current partner at time of diagnosis. One participant was afraid of transmitting HPV through oral 
sex when her boyfriend had a toothache, “he got a horrible toothache…he was really worried. He was 
like I don't know what it is, what if it is oral cancer? I was like, ‘you don't have oral cancer’... and he was 
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like, ‘HPV brings oral cancer.’ So I was concerned about oral sex because we did not use any protection 
with that” (Summer). Another worried about transmitting to a serious partner, “I felt a little guilt around 
that ... exposing him. I really loved him” (Phoebe). One participant expressed guilt about possibly having 
transmitted HPV to past sexual partners. She said that she may have unknowingly infected past partners 
due to the dormant nature of HPV, “who knows how long I have been carrying it and not showing 
anything -- and, second of all, who I may have affected along the way. I just kind of feel like a jerk. But I 
don't know there is really anything I can do about it now, just be more careful and not let it happen 
again” (Amber). Due to a lack of HPV transmission knowledge, the dormant nature of HPV, and the 
inability to have male sex partners tested for HPV, many of my participants were concerned about 
transmitting HPV to their partners, but felt unable to control the situation.  
Although the HPV vaccine reduces one’s risk for infection and thus prevents the spread of 
disease, sixteen of my participants were not vaccinated. Among those not vaccinated, the most cited 
reason was that the vaccine was not available to them pre-diagnosis. Seven participants stated that they 
would have gotten the vaccine if that had been an option for them. These participants were either 
diagnosed before the HPV vaccine was manufactured or they were diagnosed when they were past the 
recommended vaccination age cut off of 26. One complained about the vaccine age cut off stating: “this 
really sucks because I would have taken the HPV vaccine. I get that they want to target people before 
they become sexually active and by 40, most people have had it, but clearly I am the outlier” (Colleen). 
Another reflected on the availability of the vaccine for younger aged women stating, “when they [HPV 
vaccines] came out I was already past 26, I was like, damn it, they [younger women] get it so much 
easier now” (Riley). Although the vaccine is recommended for younger men and women and not 
covered by insurance past the age of 26, many of my participants could have opted to pay out-of-pocket 
for it. This was information that most of my participants were unaware of at the time of interview. 
Without this information, they were unable to utilize this method to prevent their own infection and 
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transmission to their sex partners. Three of my participants opted to receive the vaccine after testing 
positive for HPV. They used it as a method to prevent against “flare-ups”, developing cancer, or 
acquiring another strain of HPV that caused warts. Two received the vaccine at the recommendation of 
her doctor, while another had to insist on getting the vaccine. She recalled that many people in her life 
said, “you already have HPV; this [the vaccine] is not going to help you” (Theresa). She, however, 
decided to get vaccinated anyway. 
 
4.6.2 Impact on Sexual Behavior 
4.6.2.1 Risky Sex 
Twelve participants, were in a monogamous relationship at the time of interview. All of these 
individuals disclosed their HPV status to their monogamous partners. Nine of these individuals did not 
use barrier methods (condoms, dental dams) with their monogamous partner. Two of these participants 
did not use barrier methods because they did not have sexual intercourse with their partner. One of 
these abstained due to pain associated with intercourse from chemotherapy and scar tissue. The other 
participant who did not have intercourse, chose to abstain as a protective measure until she and her 
partner were treated for HPV. One participant did not use barrier methods because HPV had cleared 
from her body before beginning her current monogamous relationship. 
Six participants did not use a barrier method with their monogamous partner, were still HPV+, and 
continued to have sexual intercourse. Although some of the participants used a condom during their 
first sexual encounter with this partner, none continued to use condoms due to testing negative for 
other STIs, being on birth control, or trusting that their partner did not have any other STI. One stated 
that her reason for not using condoms was because she “assumed he probably already had it” (Carla). 
This individual was not concerned about passing HPV on to her partner because she knew how common 
it was and did not understand the potential health consequences for men. Another cited her trust in her 
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partner as a reason to not use condoms: “you can never know 100% but we have been together 12 
years and I trust him so ... as far as I know, we have only ever been sexually active with one another 
since we were like 17. Because of that we knew fairly early on in our relationship that this was a long-
term thing and, um, so we weren't super concerned about safer sex practices. I was always on some 
form of birth control but we did not worry a lot about STIs because I think we felt comfortable in each 
other’s commitment” (Leah). This individual worried about transmitting to her partner and asked him to 
see a doctor. Once the doctor told them that her male partner had no external physical abnormalities, 
so they assumed he was HPV free. Another participant stated that she only used condoms with her 
current partner during their first sexual encounter and did not consider using condoms post diagnosis, 
“because I knew I already had it and even if I got it from someone else, I had been sexually active for 
about 6 months with my current partner so either I had it and for sure now he has it or I just got it from 
him anyway” (Ava). Another stated, “I was sure we both already had it from years and years of 
unprotected sex…. Theoretically if [my husband] had gotten it too, we could just keep giving it to one 
another” (Andrea). These participants’ experience highlight that an inability to test men and assumed 
positive status based on high prevalence can lead to transmission and even reinfection between 
partners. 
Eleven participants were single or in non-monogamous relationships at the time of interview. Three 
of these participants did not use condoms, but did disclose their HPV status to some of their partners. 
One of these participants told a few of her recent sexual partners about having HPV, but did not practice 
safer sex with them because they did not ask to use condoms once they knew about her status. When 
telling one partner her status she told him “how common it was. That men are the carriers. That he 
probably already had it anyways” (Leslie). One participant told her primary partner right after diagnosis, 
but they did not start practicing safer sex: “I went home and told my partner. We did not start using 
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condoms” (McKenzie). She did, however, mention practicing safer sex with her other sexual partner, 
although she did not disclose her status to them.  
Three of the participants who did not use condoms also did not disclose their HPV status to their at-
risk partners. One participant disclosed her status to her husband, but has not disclosed to any new 
partners since their divorce. She did not use condoms with her husband or the more recent partners. 
She demonstrated that this was related to a lack of knowledge, “there was not a lot of information 
about that [HPV in men] and by the time there was information we were divorced” (Katherine). Another 
individual did not disclose her status or start using condoms with a casual sex partner because, “we had 
already been having sex and already not using a condom at that point so I was like... he's screwed 
already…. It was only after both of us tested for STDs that we started not using condoms, but again, I 
didn't tell him about the HPV” (Whitney). One participant, who did not tell some of her recent sexual 
partners, cited disliking condoms as her reason for not using protection against transmitting HPV: 
“condoms suck. Nobody wears condoms and if you do you are not having very good sex because 
condoms are lame. Having HPV has not changed anything.  Like I really don't use condoms and I don't 
think HPV merits that” (Emily). She asserted that she was having casual sex with people whom she 
trusted, “like if I was having random stranger sex I would of course wear a condom and probably not 
even have sex with them. But condoms just suck. That is it. I don't like them. And just because I have 
HPV, I won't use them” (Emily). The lack of barrier method use among these participants at least in part 
resulted from misinformation about how HPV is transmitted, how men are impacted by HPV, and the 
inability to test men for HPV. 
 
4.6.2.2 Safer sex 
Fourteen participants used barrier methods with some of their sex partners who were at risk for 
contracting HPV. One participant recalled using dental dams and gloves with her current female partner: 
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“I did start a relationship many months later. I have only had sex with women and I have a female body 
so I had never had to use a dental dam or gloves, and I was like ‘are you freaking kidding me’... it was 
not as much fun. And my girlfriend was great at the time, she was like ‘we will figure it out, it will be 
fine’. I was like ‘seriously? Gloves?’...but she was understanding. And until we were sure of it - that the 
HPV had been cleared up and I was ok… yeah it changed things drastically” (Jessie). Thirteen participants 
specifically mentioned using male condoms. Eleven of these participants continued using condoms after 
diagnosis, a practice they started before knowing they were HPV positive. Two participants who used 
condoms stated that their diagnosis motivated them to practice safer sex than they had previously. One 
said, “I was having it [safer sex] more often after the diagnosis” (Tiffany). 
Four of the participants who continued or began to use condoms post diagnosis, disclosed their 
status to all of their at-risk partners, one disclosed to some of her casual partners, and another disclosed 
only to her primary partner. One stated, “up until we got married we always used condoms. I went on 
birth control and it did not suit me so we always used condoms not to have children. So using them 
protected us I guess from passing it [HPV] back and forth” (Summer). One participant vaguely alluded to 
having safer sex, “[I am] more careful, but that was something that kind of happened naturally with 
growing up and having more respect for myself. It's [HPV diagnosis] just kind of reinforced that… in 
terms of being promiscuous or sleeping around, those days are over. Not just because of that 
[diagnosis], emotionally I have grown beyond it” (Amber). This individual did not explicitly state that her 
safer sex practices included using condoms or other barrier methods.  
Four of the participants who did not disclose their status to sexual partners stated that they 
practiced safer sex post diagnosis. Two of these participants used condoms with every sexual partner 
while HPV positive. One stated that since her first boyfriend, every other encounter has been “100% 
condoms every single time, non-negotiable” (Collen). Another stated that she, “used condoms with 
those sex partners.... It was a standard for me at the time. I wasn't on birth control so I would not have 
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not used condoms. It wasn't about HPV… just general safe sex” (Phoebe). One participant noted that she 
did not use condoms every time she had sex after diagnosis, just more often. This participant felt that 
her more frequent condom use warranted not disclosing her status, “I was being more cautious though, 
and using more condoms too. I was like, ‘ok, if we are using condoms I don't need to tell you’” (Tiffany).  
 Although fourteen of my participants used barrier methods with some or all of their sex 
partners at risk for contracting HPV, thirteen of these only used condoms. Condoms alone do not 
prevent transmission of HIV because it can be contracted through skin-to-skin contact and does not 
require penile-vaginal or penile-anal penetration. A more effective way of preventing HPV transmission 
would have been to use multiple barrier methods, such as condoms during vaginal, anal and oral sex and 
dental dams during oral sex. Only one participant used dental dams, however, and she stated a common 
barrier to using this method: “I mean this is so clinical. It was really not fun” (Jessie).  
 
4.6.2.3 Less Sexual Activity 
Ten participants, in total, recalled having less frequent sexual encounters after their diagnosis. Five 
of these had disclosed their status to their current sexual partner. Those who had disclosed cited both 
the diagnosis and the related treatments as sources for their decreased sexual activity with their 
partners. One participant mentioned thinking negatively about sex because of the diagnosis: “I 
remember right around the time feeling a little less horny, like I had less desire to have sex because I 
was like, this is what happens when you have sex, this kind of fucked up shit” (Summer). Another cited 
fear of transmitting HPV to her female partner and acquiring it again as a reason to avoid sexual 
intercourse. To protect each other, they “primarily just [do] not having sex…We make out sometimes 
and feel each other but we don't get anywhere close that things could be exchanged” (Amber). One 
participant that linked her related treatments to decreased sexual activity stated that her partner was 
supportive of her during this difficult time, “because of the scar tissue from the surgeries [multiple cold 
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knife conizations15], my cervix is closed the same way a woman in menopause cervix is closed... It has 
affected me because most of the time sex is painful. My fiancé, he loves me to death so he works with 
me and doesn’t pressure me about it or get upset about it. He understands. But it is definitely 
something that impacts me sexually in being confident as well during sex” (Kaylee). Another said that 
being no longer sexually active was a consequence of HPV-related cancer radiation, “because of all of 
this and the after effects of radiation, we are no longer intimate with intercourse. So I am not able to 
partake that way” (Theresa). However, she mentioned that she would also have stopped being intimate 
with her partner because of her positive status alone: “It [sex life] would probably change because I 
would not have been comfortable having unprotected sex. I couldn't sit there and be in a relationship 
being a detriment to somebody's health, basically” (Theresa). Another individual whose sexual activity 
lessened at time of diagnosis and during treatment stated “Our sex life did start to change - I think... we 
started having sex less frequently… We would start to have sex and I would just not want to keep going 
and I would stop feeling it... for whatever reason would be turned off...I remember especially after 
getting the colposcopy I was not feeling well and was not interested in having sex” (Erica). All of these 
participants disclosed their status to their sex partners and felt supported in their decision to have less 
frequent sex or abstain due to their status and/or consequences of treatment.  
Five participants who did not disclose their status to their current partner, recalled participating in 
less sexual activity since their diagnosis. Two of these participants mentioned that their sexual activity 
decreased or stopped completely after diagnosis because of their status. One explained how her 
diagnosis impacted her sex life, stating: “the desire [to have sex] was there but the will definitely 
decreased…. We don't do it very often at all and I avoid it a lot…. I am just going to hold out as much as I 
can until next year when I get my next pap smear. Yeah try to space it out [sex] as much as possible” 
                                                 
15 Cold knife conization surgery removes a portion of abnormal cervical tissue with a scalpel for examination. This 
method causes significantly more bleeding than LEEP and often requires general, epidural, or spinal anesthesia.  
The use of this method of conization has decreased since LEEP became widely accepted (Nyirjesy 2015).  
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(Kendra). One participant who was single at the time of the interview also felt her sex life was impacted 
by diagnosis, “Yes, right afterwards yes. I was tested in November and I don't think I was sexual at all for 
a couple of months. It was just a bummer.... It makes you not interested” (Whitney). Three of the non-
disclosing participants did not feel their diagnosis impacted the frequency of their sexual activity at time 
of diagnosis, but recalled how HPV-related procedures and recovery caused them to be less sexually 
active. One recalled, “the fact that I needed to take 6 weeks after the procedure and not be available… it 
made me feel upset because it made me feel like my body was not cooperating with me” (Candace). 
Another stated, “it took a really long time to heal. For the longest time I had - they weren't scars but you 
could see - and the skin was really thin so for a really long time sex hurt. I could not have sex for long 
periods of time after that but now I am back to normal but it too a really long time to heal because it is 
such vulnerable skin down there. That was very difficult and uncomfortable” (Emily). One participant’s 
sex life was not impacted at diagnosis, but has since become sexually inactive due to the HPV and anal 
cancer-related procedures stating that future sexual partners are “highly unlikely. I don't have much to 
work with - that makes it somewhat difficult” (Katherine).  
Ten of my 23 participants’ sex lives were impacted by having HPV. Many reported painful sex, long 
recovery from HPV treatment, and long-term consequences of treatment as the main reasons why their 
sexual activity lessened or stopped completely. Those who disclosed their status to partners felt 
supported in their choice to have less sex. Some of my participants avoided sex with their committed or 
casual partners who were unaware of their status. This avoidance was often rooted in their reasoning to 
non-disclose, as discussed below.  
 
4.6.3 Non-Disclosure 
Sixteen of my 23 participants did not disclose their HPV status to one or more of their sexual 
partners. Most of the sexual partners they did not inform were at risk for acquiring HPV because they 
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were recent or current sexual partners. Reasons for non-disclosure varied from merely never discussing 
STIs, to avoiding embarrassing and hard conversations, to believing their partners were at little risk for 
contracting HPV from them. 
 
4.6.3.1 Difficult Conversation 
One individual explained that they did not disclose to their current sexual partner merely because 
they never spoke about STIs. She came to that realization when stating, “wow, 16 years and we have not 
had that kind of conversation” (Tiffany). Six participants, however, purposefully withheld their positive 
HPV status from current or past sexual partners because they believed it would be a difficult 
conversation to initiate. Two individuals decided not to mention their status because they feared sexual 
rejection from their partners, “I did not want to risk them having a bad reaction and not want to have 
sex with me. I did not want to deal with it or disclose so I did not disclose at that time” (Phoebe). 
Another stated, “it's an embarrassing thing to have…. What is telling him going to do, except probably 
have him not see me anymore?” (Whitney). One participant, in a non-monogamous relationship, was 
too embarrassed to disclose to any secondary or tertiary sexual partners, “I think it [reason for non-
disclosure] is embarrassment and shame. It has less to do with rejection. I don't really care about that 
from those folks. I just don't think it is necessary. I think that is not a rational response. This part of me 
just doesn't want to tell anybody” (McKenzie). One individual disclosed to their current sex partner, but 
not to past partners at risk because it would be a “difficult” conversation with these past sexual partners 
(Summer). One did not disclose her status because she believed it was a result of infidelity, “it 
[disclosure] would have been me telling him I got HPV from cheating on him” (Phoebe). Another 
participant does not plan on telling future sex partners, explaining that conversation was too intimate: 
“do I feel like I need to talk about it with someone that I am just having sex with? No, because I don't 
feel like it is important. It is more deep than I want that relationship to be. I just want someone to come 
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hang out, we have sex, you can go” (Emily). All of these participants actively avoided having a 
conversation with some of their at-risk sex partners about their positive status, but some of them did so 
because they assumed their partner was also HPV positive. 
 
4.6.3.2 Little Risk to Male Partners 
Over half (14 of 23) of my participants did not disclose their HPV status to at least one of their male 
sexual partners because they believed there to be little risk of new transmission or few negative physical 
consequences for their male partners. Four individuals chose not to tell their sexual partners about their 
HPV because they assumed the partner had already contracted it, “I never talked to sexual partners 
before we have sex like ‘I have HPV, just want to let you know’ because they probably have it too” 
(Emily). Another recalled, “I remember offhandedly being like ‘well obviously I have HPV so obviously 
you do too’” (Phoebe). One stated, “the people that I have had sex with are around my age so I am sure 
that everyone has HPV and there is literally nothing that you can do about it” (Colleen). Another said she 
would not tell her sex partner “because he is already a carrier there is nothing I can do about it” (Ava). 
One participant thought it was too late to prevent transmission and therefore did not mention it to her 
partner, “we had already been having sex and already not using a condom at that point so I was like... 
he's screwed already…. It was only after both of us tested for STDs that we started not using condoms, 
but again, I didn't tell him about the HPV…. I'm a jerk” (Whitney). All of these participants decided to not 
disclose their status to sex partners because they assumed their partner had it previously or had already 
contracted it from them. They felt there was little to gain for either partner by disclosing their status. 
Three participants did not think to tell their male partners because they knew it was something 
men could not get tested for, “there is no way to easily test on a man. I just don't think it is that big of a 
deal” (Emily). One individual stated, “I think it was a matter of just did not think to. I know that sounds 
odd but yeah. I guess probably because male partners really can't get tested for it” (Katherine). Another 
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stated that disclosure is unnecessary for this reason, “If I called someone now and told them that [I had 
HPV] they would laugh at me… I really do feel like that because really what are you supposed to do? He 
can't... he won't ever know if he has it” (Ashley). Four individuals thought HPV would not impact male 
partners and thus did not disclose, “it is not going to affect them in any real way except give them this 
random information that they can do nothing with... what is the point” (Ashley). Another did not feel 
the need to mention it to her past male partners, “I don't really see the point in doing so [disclosing] 
because the two people I am thinking of are both men and they wouldn't have any symptoms if they 
have what I have” (Amber). One said she did not disclose to her partner “because it is not going to affect 
him” (Ava). One of these participants did not consider telling their partner, “I did not even think about it. 
This is the first time I have thought about it… because it is transmittable, right?” (Janelle). All of these 
participants did not feel compelled to disclose their positive status because they knew their male 
partners would not be able to find out their own status. One participant, who disclosed only to her 
current sex partner, asked the diagnosing doctor for advice about disclosing to sexual partners and 
recalled, “I did ask him [doctor] questions about if it would impact my partner because my boyfriend 
was worried about it as well. The gynecologist wasn't as concerned about how it would affect partners 
unless they were female partners. He was like, ‘well, you can't test on guys so there is nothing I can do 
or advise on that’” (Erica). This patient-provider exchange supports my participants’ motivations to not 
disclose to male sex partners. 
Three participants did not tell their past sexual partner because they were having safer sex. One 
felt no need to tell her partner because they were using condoms and she wanted, “just not to have to 
deal with the whole process of explaining the diagnosis and whether the person may have been familiar 
with it or understood it or anything… just to not have to deal with that... not necessarily the proper thing 
to do” (Tiffany). Another stated, “that [disclosing] is an awkward conversation starter and I knew that 
we were practicing safe sex and it wasn't a huge risk” (Kendra). One individual similarly explained, 
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“Unless they asked if I had an STD before I didn't really say. I didn't really think it was a big deal. Maybe I 
was wrong in that thinking but since we were using condoms and it was the cervical cancerous kind, I 
was not really concerned about my male counterpart” (Leslie). As mentioned above, these participants, 
while aware of the protective effect of condoms, were not aware that using additional barrier methods 
would decrease the likelihood of transmitting HPV. 
Six individuals mentioned that they would disclose other STIs that were more serious in their 
eyes. One participant compared it to other STIs when rationalizing non-disclosure stating, “HPV is very 
different. If you have any other kind of STD… a disease is different than an infection. A disease is really 
fucked up. When you have unprotected sex with someone you are taking a risk of faith on them and 
they on you” (Emily). Another explained, “I think you know with the herpes HSV the fact that you can 
give it to someone else and it is a lifelong thing and doesn't clear up…. it is also cosmetically not pretty. I 
would definitely disclose that or my sexual behaviors would change. If it was HPV with genital warts - 
yeah I would have said something” (Leslie). Another said, “it still did not occur to me to tell about HPV, 
but I will disclose about HSV” (Candace). One individual stated, “I was thinking in my mind that if the 
results were positive [for HSV] that I would call and tell him [sex partner] because he was the only one I 
had been with since then but this [HPV] did not seem that serious, like I did not need to make a phone 
call. This one [HPV] does not seem so scary because she [nurse] told me it would go away” (Janelle). 
Another participant, who had not disclosed to their most recent partner, mentioned how other STI 
diagnoses would impact disclosure and sexual behavior. They stated, “if I was diagnosed with HSV2 I 
would feel shitty about that even though I know how prevalent that is too… I would feel a responsibility 
to disclose and I don't want to do that. If I were diagnosed with gonorrhea or chlamydia I would think 
that sucked, but it would not be a big deal because I would take the antibiotics and be done with it. I 
would probably not have sex until it cleared. I would probably tell my current sexual partner and hold 
off until it cleared. I would not have sex with a new partner while under treatment for chlamydia” 
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(Phoebe). Another said, “if it was something that would affect my health and if it happened to other 
women and would affect their health severely - like if it was something like I don't know much about 
other STDs but definitely like AIDS or like - things that cause long symptoms I would have gone back and 
informed” (Ava). All of these participants felt that HPV was not serious enough to warrant diagnosis 
disclosure.  Again, all 14 of the above participants did not disclose because of a lack of knowledge 
regarding HPV’s impact on men. They did not believe they were putting their male sexual partners at 
risk for HPV or HPV-related consequences, such as genital warts, penial, or throat cancer.  
 
4.6.3.3 Clearance and Prevalence  
 
Two participants did not disclose their HPV status because they knew it was highly prevalent, “I 
think I was like well it is so common it does not matter. It wasn't something I thought of… like a thing I 
need to disclose” (Phoebe). Another stated, “I never thought to disclose that I had it to partners. It 
didn't even occur to me. It was just abnormal cells and basically everyone has it is” (Candace). Two no 
longer disclosed because HPV has cleared from their bodies, “in the last year it has been clear so I 
stopped telling partners” (McKenzie). Another who no longer tests positive for HPV stated, “I think it is 
irrelevant if it is not a current thing” (Riley). These two participants disclosed their status to most of their 
sex partners when they still tested positive for HPV, but felt that they no longer had it to transmit and 
thus, no longer needed to disclose.  
 
4.6.3.4 Guilt 
Three participants expressed some guilt due to their non-disclosure. One stated, “if I feel bad about 
anything it is not disclosing [to the secondary and tertiary partners]” (McKenzie). Another recalled, “I 
didn't tell him about the HPV… I'm a jerk (Whitney). Another who believed she acquired HPV from sex 
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outside of her relationship stated, “I am sure I felt a little guilt around that - exposing him[boyfriend]. I 
really loved him” (Phoebe). Despite feeling guilt for non-disclosure, these participants chose not to 
disclose for multiple reasons: it was a difficult conversation to have, believed there was little HPV risk to 
men, and knew HPV was extremely common. Two of these participants did not use condoms with their 
at-risk partners. 
 
4.7 LIMITATIONS 
Past qualitative research on HPV has relied on non-diverse samples of primarily white, college-
educated women (see: Kosenko et al. 2012, Nack 2008). Although I sought to reveal the stories of a 
diverse sample in terms of ethnicity, race, and educational attainment level, my sample was more 
homogeneous than initially intended. My sample included cis-gender and gender non-conforming 
women from different racial and ethnic groups ranging in age. However, I was unable to include 
participants of varying levels of educational attainment. This may have been a result of my sampling 
method. However, I also believe it is due to the fact that women with lower socioeconomic status and 
less education are less likely to have regular gynecological appointments and routine Pap tests, 
compared to their more educated peers (Behbakht et al. 2004; Katz and Hofer 1994). Without regular 
visits to the gynecologist and routine Pap tests, women are much less likely to know they are HPV 
positive. Therefore, individuals who saw my flyers may have thought they did not qualify because they 
did not know their positive status.  
 
4.8 DISSCUSSION 
According to past research, individuals with HPV are often unaware of symptoms, risk of 
transmission, and recommended lifestyle changes (Perrin et al. 2006; Sharpe et al. 2006). Use of barrier 
methods (condoms, dental dams) and disclosure of HPV status are two prevention strategies that can be 
 86 
used by individuals who are HPV positive. These behaviors, while not 100% effective at preventing the 
transmission of HPV, can prevent initial acquisition, transmission to partner, and re-infection among 
partners. Although many Americans are unaware of the potential of HPV re-infection after clearance, re-
infection with the same HPV type is a common occurrence (Trottier et al. 2010). Many women with HPV 
do not disclose their status to partners because of this lack of knowledge and feelings of shame for 
having an STI (East et al. 2012; McCaffery et al. 2006; Nack 2008). Some individuals with HPV, according 
to past research, do not use barrier methods to protect against transmission to their partners (Nack 
2008).  
According to the information, motivation, behavior (IMB) theoretical model, STI prevention 
techniques are used by individuals who are well informed, perceive themselves to be at risk, are 
motivated to change their risky behavior, and feel capable of using prevention strategies (Bahrami and 
Zarani 2015; St. Lawrence and Fortenberry 2007). In order to participate in STI risk-reducing behavior, 
according to the IMB model, individuals must be informed about STI risk-reduction (St. Lawrence and 
Fortenberry 2007). Specifically, people need to be knowledgeable about STI transmission and 
prevention methods (Fisher and Fisher 1992; St. Lawrence and Fortenberry 2007). Many individuals are 
unaware that STI disclosure is a component of safer sex practices (Luchetti 2009). The majority of my 
participants did not disclose their HPV status to one or more of their sexual partners. According to past 
research, much of the general population is unaware of their risk of acquiring and transmitting HPV 
(Blake et al. 2015; Gerend and Magloire 2008; Sandfort and Pleasant 2009; Ratanasiripog et al. 2013). 
Although some of my participants were concerned about transmitting HPV to their partners, the 
majority of them did not know that HPV could be transmitted from skin-to-skin contact. Past research 
indicates that people are also misinformed about how HPV impacts men and believe there are no HPV-
related health threats for men (Sandfort and Pleasant 2009). Fourteen of my participants who did not 
disclose to a male sex partner were unaware of the HPV-related health consequences for men. 
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Individuals who participate in oral sex often do not understand STI transmission through oral sex, and 
are unaware of prevention methods (dental dams) to use during oral sex (Chambers 2007). Only one of 
my participants used dental dams to protect against transmission. None of my heterosexual participants 
used this barrier method to prevent transmission through oral sex.  
Knowledge alone is not sufficient enough to change behavior, according to the IMB model 
(Fisher and Fisher 1992). Informed individuals must be motivated to act on their knowledge and change 
their risky behavior (Fisher and Fisher 1992; St. Lawrence and Fortenberry 2007). They must have the 
strong desire to initiate and maintain prevention strategies, such as condom use, dental dam use, and 
status disclosure. This motivation is, in part, related to one’s perceived susceptibility to risk and 
adherence to social norms surrounding prevention techniques (Fisher and Fisher 1992). Consistent 
condom use is associated with perceived risk to STIs (Bryan et al. 1997). However, many people often do 
not perceive themselves at risk for HPV (Gerend and Magloire 2008; Sandfort and Pleasant 2009; 
Ratanasiripong et al. 2013; Blake et al. 2015). Many of my participants were unaware of the high 
prevalence of HPV, even after their own diagnosis. Normative behavior related to condom use differs for 
individuals in committed relationships compared to those in casual sexual relationships. Individuals in 
serious relationships are less likely to use condoms, compared to single individuals, because as trust and 
a sense of security increases in the relationship, condoms are no longer viewed as a necessary 
precaution (Emmers-Sommer et al. 2010; Roberts and Kennedy 2006). The majority of my participants in 
monogamous relationships did not use condoms or other barrier methods to prevent HPV transmission 
and reinfection. Many of these individuals used condoms at the beginning of their relationship, but 
discontinued use once they trusted their partner, had been tested for other STIs, or went on hormonal 
birth control. Motivation to disclose status, among those with HPV, is often thwarted by fear of 
rejection, embarrassment, and feelings of shame (East et al. 2012; McCaffery et al. 2006; Nack 2008). 
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Some of my participants withheld their status from partners because they were embarrassed or worried 
that their partner would reject them. 
In order for a knowledgeable, motivated individual to actually change their risky behavior, they 
must have the skills to perform the recommended preventive behaviors (St. Lawrence and Fortenberry 
2007). These skills include obtaining a vaccine, correct condom use, sexual communication, condom 
negotiation, and a sense of condom use and condom negotiation self-efficacy (Fisher and Fisher 1992). 
Individuals must feel that they are skilled enough to act on their knowledge and motivations in order to 
change their risky behavior or initiate and maintain preventive behavior (Fisher and Fisher 1992). HPV 
vaccination intention and uptake is lower among older adolescents and college age women due to 
vaccine safety concerns, side effects, insurance issues, cost, low perceived risk, and belief they are too 
old to receive the vaccine (Laz et al. 2013; Patel et al. 2012). Most of my participants never received the 
HPV vaccine because they did not qualify for insurance coverage based on age, were diagnosed before 
the vaccine was readily available, or were unaware of the vaccine before diagnosis. In support of 
previous research (see: East et al. 2012; McCaffery et al. 2006), some of my participants were unable to 
disclose because they were embarrassed, feared sexual rejection, and did not feel confident in having 
the difficult conversation about their status. Actual condom use is related to condom use and 
negotiation self-efficacy (Bryan et al. 1997). In some studies, women report lower condom use self-
efficacy scores than men and often report not using condoms because their male partner does not want 
to (Farmer and Meston 2006; Roberts and Kennedy 2006; Wildsmith et al. 2010). Other researchers, 
however, posit that women have greater condom use and condom negotiation self-efficacy (Allen et al. 
2002; Carter et al. 1999). Some research demonstrates that women with HPV become more assertive 
about condom use with their partner post diagnosis to avoid transmission and re-infection (Nack 2008). 
Some of my participants practiced safer sex post diagnosis because they feared transmitting it to their 
partners. Many, however, felt incapable of preventing HPV transmission through the use of condoms 
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because they assumed their partner already had HPV or they knew that condoms would not completely 
protect their partner.  
I found, in support of past research (see Bertram and Magnussen 2008; Kosenko et al. 2014; 
Perrin et al. 2006; Sharpe et al. 2006), that many individuals with HPV are misinformed about the 
transmission of HPV and HPV-related health consequences for men. My participants’ lack of perceived 
risk for transmitting HPV; inaccurate knowledge about HPV transmission, prevention, and consequences 
for male partners; and low self-efficacy for preventing the spread of HPV all impacted their decisions 
about disclosure and sex behavior post diagnosis. Based on my research, I recommend that practitioners 
discuss transmission, prevention methods, and the potential consequences of putting their partners at 
risk. Individuals with HPV will not be able to prevent the continued spread of this highly prevalent STI 
unless they are well informed about transmission and prevention, perceive themselves to be at risk for 
re-infection or for infecting others, are motivated to use prevention methods, and feel capable of sexual 
communication and condom negotiation with their partners. 
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5 CONCLUSION 
In this study, I used semi-structured interviews to uncover the lived experiences of individuals 
with HPV. This method, compared to past HPV scholarship which heavily relied on survey research, 
fostered discussion of actual experiences related to living with HPV, specifically knowledge, stigma, 
disclosure, and sexual behavior. I sought to discover (1) whether individuals diagnosed with HPV were 
knowledgeable about the infection prior to and after diagnosis, (2) how those diagnosed with HPV felt 
about themselves after diagnosis and how their knowledge of HPV influenced these feelings, (3) why 
they decided whether or not to disclose their status to family, friends, and sexual partners, and (4) how 
HPV status influenced my participants’ sex life and use of STI prevention methods. 
As a whole, my dissertation highlights how patient-provider interaction surrounding HPV 
diagnosis greatly impacts individuals’ emotions, disclosure, and sexual behavior post diagnosis, in 
addition to their general knowledge of the STI. Unsympathetic, impersonal, uninformative patient-
provider interactions often led my participants to negatively view their status, feel shame, internalize 
stigma, be misinformed on HPV transmission, withhold their status, and participate in unprotected sex 
with their at-risk partners.  
Despite the high prevalence of HPV, health literacy and basic knowledge about it remain 
relatively low. Health literacy is positively associated with level of education, however, even among my 
participants, who represented a highly educated portion of the population, HPV knowledge pre-
diagnosis was low. Pre-diagnosis, many of my participants were uninformed about HPV prevalence, 
transmission, and cancer facts. After diagnosis, participants often remained unaware of HPV’s skin-to-
skin transmission, clearance, and dormancy, thus demonstrating a continued low HPV health literacy.  
An HPV diagnosis, similar to other STI diagnoses, often causes concern and anxiety. The majority 
of my participants experienced feeling anxious, scared, or stressed when they were first diagnosed with 
HPV. Many also expressed surprise and shame over their positive status. All participants who received 
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word about their diagnosis from a nurse rather than their primary doctor, or who had an experience 
where their clinical staff assumed their status was already known, recalled these negative emotions. 
Very few of my participants mentioned feeling supported and having their worries assuaged by their 
doctors.  
Women with HPV possess a character stigma because they deviate from societal norms of 
female chastity and purity. They can be viewed as promiscuous, irresponsible, and unclean. A majority 
of my participants felt stigma related to their positive status. Many assumed that others judged them 
based on the fact that HPV is an STI and thus, indicated they were not sexually responsible. Others 
believed they were facing stigma because of the type of cancer they developed from HPV – anal cancer, 
which they knew others were quick to pass judgement on. Many participants internalized this stigma 
and felt shameful about their diagnosis and blamed themselves for their status. Some of my 
participants, however, did not experience stigma related to their status, but realized that others with 
HPV may face judgment from larger society.  
Individuals with a hidden, discreditable stigma must decide who to tell or not tell about their 
condition. Some may choose to disclose their character stigma to friends, family, or partners for 
support. Others may decide to hide their status because of internalized shame and embarrassment. 
Almost all of my participants disclosed their HPV status to someone in their life. Some participants who 
felt stigma sought support or advice from friends who had previously experienced HPV themselves. Even 
individuals who felt little to no stigma often disclosed to gather the same information. Many of these 
individuals (both those that felt stigma and those that did not), in turn, were open about disclosing to 
others who were newly diagnosed and wanting information or advice. Some of my participants withheld 
their status from specific individuals in their life. They used this form of stigma management, selective 
disclosure, because they knew they would face judgement from those people. Even some participants 
 92 
who felt little to no stigma attached to their status chose to selectively disclose by only mentioning their 
treatments and not the fact that they were HPV related.  
My participants had a variety of HPV types and stages of cervical dysplasia. Some individuals had 
low-risk, asymptomatic HPV strains that posed little to no risk to their sexual partners. Many others, 
however, had high-risk strains or mild to severe dysplasia caused by HPV. Transmitting these types of 
HPV to sexual partners posed risks to them, depending on the specific strain of HPV - which most 
participants did not know. These high-risk HPV strains could also be consequential for male partners’ 
future female partners. Although a high-risk strain may have cleared from my participants’ bodies, they 
could become re-infected after treatment if they have already transmitted it to their current partner. A 
few individuals had anogenital warts caused by HPV, which were easy to transmit to one’s partner 
through sexual intercourse or skin-to-skin contact. Others did not know what type of HPV or cervical 
dysplasia they had at the time of interview and without this knowledge, these individuals were unaware 
of the potential risk they may have been causing their partners or their partners’ future partners.  
Secondary STI prevention methods, which prevent transmission from a positive individual to 
their partner, are more likely to be used if individuals are informed about transmission and prevention 
techniques, motivated to practice preventive behaviors, perceive themselves and others to be at risk, 
and are confident in their ability to perform prevention behaviors. The majority of my participants did 
not disclose their HPV status to one or more of their at-risk sexual partners. Some did not disclose 
because they felt it was a difficult conversation they did not want to initiate because of fear their 
partner would reject them, embarrassment about their status, or a disinterest in admitting to their 
infidelity. The majority of my participants, however, did not disclose their status to sexual partners 
because they did not believe they were putting their male partners at risk. Many assumed their partners 
already had HPV or saw no point in disclosing to male partners that could not get tested. Others 
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assumed they were not putting their partners at risk because they were using condoms most of the time 
or admitted that they would disclose if it were an STI they considered to be more serious.  
None of my participants, however, used all barrier methods during male-female sexual 
activities. Many used condoms on occasion, but none used dental dams with their male partners to 
prevent transmission through oral sex. Some participants felt that their diagnosis was a catalyst for 
participating in safer sex. Others, however, did not use condoms consistently and this was more often 
true for those in monogamous relationships. A few participants reasoned that they were abstaining or 
having sex less frequently as a means of protecting their partner. Most who were having less frequent 
sex post-diagnosis, however, were doing so because sex had become painful after their HPV treatments. 
The HPV vaccine reduces one’s risk for infection and thus prevents the spread of disease, 
however, it is recommended for younger men and women and not covered by insurance past the age of 
26. Most of my participants were not vaccinated because the vaccine was not available to them pre-
diagnoses or they were unaware of the vaccine before being diagnosed with HPV or reaching the 
insurance cut-off age. Many of my participants could have opted to pay out-of-pocket for the vaccine 
past the age of 26 or post-diagnosis. Research suggests that previously infected individuals may benefit 
from vaccination by increasing antibodies and thus helping individuals clear HPV more quickly and by 
preventing re-infection. This was information that most of my participants were unaware of at the time 
of interview. Without this information, they were unable to utilize this method to prevent their own 
infection, transmission to their sex partners, or potential re-infection.  
Many of my participants felt incapable of preventing the spread of HPV. This low self-efficacy 
existed even if they knew how easily it was transmitted and sometimes was rooted in this knowledge. 
Few understood that the most effective way to prevent transmission was through multiple barrier 
methods, and even fewer were motivated to start using these prevention methods after diagnosis. 
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Many of my participants saw HPV as an inescapable consequence of being sexually active, despite being 
shocked and ashamed when they were diagnosed with it. 
Participants’ low HPV health literacy, high levels of anxiety at time of diagnosis, continued 
stigma, non-disclosure, and risky sexual behavior are related to sexual education, practitioner 
messaging, and social norms around HPV. A substantial portion of the American population that is at risk 
for acquiring and transmitting HPV is unaware of many aspects of the infection. Sexual education 
programs should include curriculum on HPV related to the vaccine, transmission, dormancy, clearance, 
cancer, and prevention methods. Decades of research demonstrate that people are dissatisfied with 
how their doctors handle HPV diagnosing. Medical practitioners should strongly consider having a face-
to-face conversation with their patients when providing a positive HPV diagnosis and make sure their 
patients are fully informed about key aspects of the disease, such as prevalence, transmission, 
dormancy, clearance, and how, specifically, it is linked to cancer. To prevent the continued spread of 
high-risk HPV, normative behaviors around sex must change. Prevention programs should focus on 
heightening the knowledge about and acceptance of alternative barrier methods to STIs. In addition to 
increasing consistent condom use before penetrative sex in order to decrease transmission through 
skin-to-skin contact, prevention efforts should aim at increasing the use of dental dams to prevent the 
high-risk HPV through oral transmission. 
My small exploratory study brought to light many unknowns that still surround HPV among 
those infected. Past HPV research often relied on survey methods that did not provide rich detail about 
experiences of those who lived with HPV. Few qualitative studies before this one were conducted since 
the HPV vaccine was routinely recommended in the United States. I analyzed how routine vaccination 
and subsequent increased awareness of HPV in the general public impacted by participants. Although I 
sought to reveal the stories of a diverse sample based on ethnicity, race, and educational attainment 
level, my sample was more homogeneous than initially intended. Future research should focus on how 
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HPV knowledge varies among racial and ethnically diverse populations and how that knowledge impacts 
stigma, disclosure, and sexual behavior among those groups. A few of my participants were vaccinated 
before testing positive for HPV. Future research should focus on this small, but interesting group of 
individuals living with HPV to better understand their lived experience and attitudes toward the vaccine. 
My research shed light on how HPV impacted individual’s status disclosure and sexual behavior with 
their partners. Future, large-scale, quantitative research can analyze how these aspects of safe and risky 
sex differed among those who had low-risk HPV compared to high-risk HPV. Findings from such research 
could pave the way for new prevention efforts that aim at stopping the spread of high-risk HPV strains 
that are associated with most cervical, vaginal, vulvar, penile, anal, and throat cancer cases in American 
men and women. 
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APPENDIX: DEMOGRAPHICS 
# Pseudonym Age at Interview Age at 
Diagnosis 
Strain/ 
Dysplasia 
Vaccinated Childhood 
Residence 
Childhood 
Family 
Structure 
Educational 
Attainment 
Job  
Industry 
Race Relationship 
Status at 
Interview 
Gender 
Identity 
Sexual 
Orientation 
Residence at 
Interview 
1 Andrea 39 26 Unknown 
level of 
dysplasia 
No United 
Kingdom 
Two-parent Bachelor’s 
Degree 
Arts White Married, 
monogamous 
Woman Heterosexual Northeastern 
US 
2 Jessie 38 31 Unknown 
level of 
dysplasia 
No Southeastern 
US 
Two-parent PhD Law White Married, 
monogamous 
Gender 
Queer 
Lesbian Canada 
3 Summer 32 24 Level 3 
dysplasia 
No Southeastern 
US 
Two-parent Master’s Degree Law White Married, 
monogamous 
Woman Heterosexual Southeastern 
US 
4 Alicia   n/a   n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 
5 Whitney 47 45 Low-risk No Northeastern 
US 
Two-parent PhD Health White Single Woman Bisexual Western US 
6 Amber 2
6 
25 Unknown 
level of 
dysplasia 
Yes, age 16 Northeastern 
US 
Divorced, 
lived with 
mother 
Bachelor’s 
Degree 
Business 
Admin. 
White Committed 
Relationship, 
monogamous 
Woman Bisexual Northeastern 
US 
7 Colleen 47 38 Low-risk No Southeastern 
US 
Divorced, no 
stepparent 
Master’s Degree Health White Single Woman Heterosexual Southeastern 
US 
8 Leah 32 22 Level 3 or 4 
dysplasia 
No Southeastern 
US 
Two-parent Master’s Degree Student White Married, 
monogamous 
Woman Heterosexual Southeastern 
US 
9 Erica 27 26 Unknown 
level of 
dysplasia 
Yes, post 
diagnosis 
Southeastern 
US 
Two-parent Graduate 
Student 
Law White Committed 
Relationship, 
monogamous 
Woman Heterosexual Southeastern 
US 
10 Kendra 22 22 Low-risk Yes, age 12 Southeastern 
US 
Two-parent Undergraduate 
Student 
Student Black Single Woman Heterosexual Southeastern 
US 
11 Madison n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 
12 Kaylee 27 26 Severe 
dysplasia 
Yes, age 19 Southeastern 
US 
Two-parent GED Arts Black Committed 
Relationship, 
Woman Heterosexual Southeastern 
US 
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(level 4) monogamous 
13 Theresa 62 60 Anal cancer Yes, post 
diagnosis 
Canada Divorced, 
lived with 
father 
Master’s Degree Education White Committed 
Relationship, 
monogamous 
Woman Heterosexual Canada 
14 Carla 35 32 High-risk Yes, age 25 Southeastern 
US 
Two-parent Bachelor’s 
Degree 
Marketing White Committed 
Relationship, 
monogamous 
Woman Heterosexual Southeastern 
US 
15 Leslie 30 22 Mild 
dysplasia 
Yes, post 
diagnosis 
Southeastern 
US 
Two-parent Master’s Degree Health White Single Woman Heterosexual Southeastern 
US 
16 Candace 31 19 Unknown 
level of 
dysplasia 
No Midwestern US Two-parent Master’s Degree Health Black Single Woman Heterosexual Southeastern 
US 
17 Tiffany 39 31 Unknown 
level of 
dysplasia 
No Midwestern US Single 
mother 
Some College Health Black Single Woman Heterosexual Southeastern 
US 
18 Ava 23 22 warts No Midwestern US Two-parent Bachelor’s 
Degree 
Education White Committed 
Relationship, 
monogamous 
Woman Heterosexual Southwestern 
US 
19 Emily 25 19 warts No Southeastern 
US 
Divorced, 
step families 
Master’s Degree Arts Biracial 
(White/ 
I
ndian) 
Single Woman Heterosexual Southeastern 
US 
20 McKenzie 50 25 Low-risk No Southeastern 
US 
Single 
mother 
Master’s Degree Health White Married, non-
monogamous 
Woman Bisexual Western US 
21 Riley 33 20 Level 3 
dysplasia 
No Southeastern 
US 
Two-parent Bachelor’s 
Degree 
Health White Committed 
Relationship, 
monogamous 
Woman Bisexual Southeastern 
US 
22 Katherine 59 28 Anal cancer No Northeastern 
US 
Two-parent Bachelor’s 
Degree 
Engineer White Single Woman Heterosexual Northeastern 
US 
23 Ashley 35 19 warts No Northeastern 
US 
Divorced, 
step families 
Master’s Degree Education White Committed 
Relationship, 
Woman Heterosexual Southeastern 
US 
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monogamous 
24 Janelle  43 43 Low-risk No Northeastern 
US 
Two-parent Master’s Degree Education Black Single Woman Heterosexual Southeastern 
US 
25 Phoebe 30 20 Mild 
dysplasia 
No Northeastern 
US 
Two-parent Master’s Degree Health White Single Woman Heterosexual Southeastern 
US 
 
